Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
136 |
1672 |
2.214e-63 |
1.03e-59 |
2 |
CELL DEVELOPMENT |
117 |
1426 |
1.234e-53 |
2.871e-50 |
3 |
REGULATION OF CELL DIFFERENTIATION |
118 |
1492 |
1.917e-52 |
2.973e-49 |
4 |
TISSUE DEVELOPMENT |
118 |
1518 |
1.213e-51 |
1.411e-48 |
5 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
104 |
1142 |
2.641e-51 |
2.458e-48 |
6 |
BIOLOGICAL ADHESION |
99 |
1032 |
1.13e-50 |
8.76e-48 |
7 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
110 |
1395 |
2.631e-48 |
1.749e-45 |
8 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
84 |
771 |
8.397e-47 |
4.884e-44 |
9 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
83 |
788 |
4.623e-45 |
2.151e-42 |
10 |
CIRCULATORY SYSTEM DEVELOPMENT |
83 |
788 |
4.623e-45 |
2.151e-42 |
11 |
ORGAN MORPHOGENESIS |
85 |
841 |
8.763e-45 |
3.707e-42 |
12 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
92 |
1021 |
1.738e-44 |
6.738e-42 |
13 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
89 |
957 |
4.774e-44 |
1.709e-41 |
14 |
RESPONSE TO ENDOGENOUS STIMULUS |
106 |
1450 |
3.092e-43 |
1.028e-40 |
15 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
82 |
823 |
1.237e-42 |
3.838e-40 |
16 |
VASCULATURE DEVELOPMENT |
64 |
469 |
2.824e-41 |
8.213e-39 |
17 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
97 |
1275 |
1.129e-40 |
3.09e-38 |
18 |
NEUROGENESIS |
101 |
1402 |
2.078e-40 |
5.372e-38 |
19 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
65 |
513 |
6.767e-40 |
1.657e-37 |
20 |
CELLULAR COMPONENT MORPHOGENESIS |
82 |
900 |
1.077e-39 |
2.505e-37 |
21 |
REGULATION OF CELL PROLIFERATION |
102 |
1496 |
1.005e-38 |
2.228e-36 |
22 |
LOCOMOTION |
88 |
1114 |
7.221e-38 |
1.527e-35 |
23 |
TISSUE MORPHOGENESIS |
63 |
533 |
8.164e-37 |
1.652e-34 |
24 |
BLOOD VESSEL MORPHOGENESIS |
54 |
364 |
1.119e-36 |
2.17e-34 |
25 |
REGULATION OF CELL DEVELOPMENT |
76 |
836 |
1.418e-36 |
2.639e-34 |
26 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
107 |
1848 |
2.209e-34 |
3.954e-32 |
27 |
POSITIVE REGULATION OF GENE EXPRESSION |
102 |
1733 |
3.472e-33 |
5.983e-31 |
28 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
77 |
983 |
1.3e-32 |
2.16e-30 |
29 |
REGULATION OF NEURON DIFFERENTIATION |
59 |
554 |
6.409e-32 |
1.028e-29 |
30 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
46 |
304 |
1.19e-31 |
1.846e-29 |
31 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
67 |
750 |
1.243e-31 |
1.866e-29 |
32 |
REGULATION OF CELL DEATH |
92 |
1472 |
1.288e-31 |
1.873e-29 |
33 |
RESPONSE TO WOUNDING |
59 |
563 |
1.555e-31 |
2.193e-29 |
34 |
CELL MOTILITY |
70 |
835 |
2.343e-31 |
3.114e-29 |
35 |
LOCALIZATION OF CELL |
70 |
835 |
2.343e-31 |
3.114e-29 |
36 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
105 |
1929 |
2.433e-31 |
3.144e-29 |
37 |
EPITHELIUM DEVELOPMENT |
74 |
945 |
2.826e-31 |
3.554e-29 |
38 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
68 |
801 |
9.16e-31 |
1.122e-28 |
39 |
REGULATION OF CELL ADHESION |
61 |
629 |
1.014e-30 |
1.21e-28 |
40 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
87 |
1381 |
5.168e-30 |
6.011e-28 |
41 |
POSITIVE REGULATION OF CELL COMMUNICATION |
91 |
1532 |
1.443e-29 |
1.638e-27 |
42 |
CELL PROJECTION ORGANIZATION |
70 |
902 |
2.784e-29 |
3.084e-27 |
43 |
RESPONSE TO EXTERNAL STIMULUS |
98 |
1821 |
1.263e-28 |
1.367e-26 |
44 |
NEURON DIFFERENTIATION |
68 |
874 |
1.742e-28 |
1.842e-26 |
45 |
POSITIVE REGULATION OF LOCOMOTION |
49 |
420 |
2.504e-28 |
2.59e-26 |
46 |
TUBE DEVELOPMENT |
55 |
552 |
2.88e-28 |
2.913e-26 |
47 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
97 |
1805 |
2.971e-28 |
2.941e-26 |
48 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
77 |
1152 |
5.024e-28 |
4.675e-26 |
49 |
REGULATION OF CELL PROJECTION ORGANIZATION |
55 |
558 |
4.972e-28 |
4.675e-26 |
50 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
69 |
917 |
4.826e-28 |
4.675e-26 |
51 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
96 |
1784 |
5.61e-28 |
5.118e-26 |
52 |
ANGIOGENESIS |
42 |
293 |
5.805e-28 |
5.195e-26 |
53 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
72 |
1008 |
6.748e-28 |
5.924e-26 |
54 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
92 |
1656 |
9.909e-28 |
8.538e-26 |
55 |
SINGLE ORGANISM CELL ADHESION |
50 |
459 |
1.684e-27 |
1.425e-25 |
56 |
RESPONSE TO GROWTH FACTOR |
50 |
475 |
8.306e-27 |
6.901e-25 |
57 |
SKELETAL SYSTEM DEVELOPMENT |
49 |
455 |
9.978e-27 |
8.009e-25 |
58 |
NEURON PROJECTION DEVELOPMENT |
53 |
545 |
9.983e-27 |
8.009e-25 |
59 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
92 |
1710 |
1.071e-26 |
8.446e-25 |
60 |
UROGENITAL SYSTEM DEVELOPMENT |
41 |
299 |
1.543e-26 |
1.196e-24 |
61 |
RESPONSE TO LIPID |
66 |
888 |
1.742e-26 |
1.329e-24 |
62 |
MORPHOGENESIS OF AN EPITHELIUM |
46 |
400 |
2.424e-26 |
1.791e-24 |
63 |
RESPONSE TO HORMONE |
66 |
893 |
2.399e-26 |
1.791e-24 |
64 |
WOUND HEALING |
49 |
470 |
4.368e-26 |
3.175e-24 |
65 |
EMBRYONIC MORPHOGENESIS |
52 |
539 |
4.634e-26 |
3.317e-24 |
66 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
88 |
1618 |
8.992e-26 |
6.34e-24 |
67 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
84 |
1492 |
1.568e-25 |
1.089e-23 |
68 |
NEGATIVE REGULATION OF CELL DEATH |
64 |
872 |
2.3e-25 |
1.574e-23 |
69 |
NEURON PROJECTION MORPHOGENESIS |
45 |
402 |
2.775e-25 |
1.871e-23 |
70 |
NEURON DEVELOPMENT |
57 |
687 |
3.284e-25 |
2.183e-23 |
71 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
48 |
472 |
4.413e-25 |
2.892e-23 |
72 |
EMBRYO DEVELOPMENT |
64 |
894 |
9.033e-25 |
5.838e-23 |
73 |
TAXIS |
47 |
464 |
1.713e-24 |
1.092e-22 |
74 |
CELL CELL ADHESION |
53 |
608 |
1.877e-24 |
1.18e-22 |
75 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
67 |
1004 |
3.189e-24 |
1.979e-22 |
76 |
TUBE MORPHOGENESIS |
40 |
323 |
3.363e-24 |
2.059e-22 |
77 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
68 |
1036 |
3.494e-24 |
2.084e-22 |
78 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
68 |
1036 |
3.494e-24 |
2.084e-22 |
79 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
39 |
306 |
4.446e-24 |
2.619e-22 |
80 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
44 |
408 |
4.566e-24 |
2.656e-22 |
81 |
REGULATION OF OSSIFICATION |
31 |
178 |
1.816e-23 |
1.043e-21 |
82 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
77 |
1360 |
1.941e-23 |
1.101e-21 |
83 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
70 |
1135 |
2.42e-23 |
1.357e-21 |
84 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
38 |
303 |
3.171e-23 |
1.756e-21 |
85 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
41 |
368 |
5.228e-23 |
2.862e-21 |
86 |
CELL JUNCTION ORGANIZATION |
31 |
185 |
6.087e-23 |
3.293e-21 |
87 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
44 |
437 |
7.444e-23 |
3.981e-21 |
88 |
REGULATION OF MAPK CASCADE |
53 |
660 |
8.765e-23 |
4.634e-21 |
89 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
51 |
609 |
9.487e-23 |
4.96e-21 |
90 |
HEART DEVELOPMENT |
45 |
466 |
1.29e-22 |
6.667e-21 |
91 |
NEGATIVE REGULATION OF LOCOMOTION |
35 |
263 |
2.525e-22 |
1.277e-20 |
92 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
60 |
872 |
2.502e-22 |
1.277e-20 |
93 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
60 |
876 |
3.154e-22 |
1.578e-20 |
94 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
87 |
1791 |
4.187e-22 |
2.073e-20 |
95 |
CELL PART MORPHOGENESIS |
51 |
633 |
5.364e-22 |
2.627e-20 |
96 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
51 |
643 |
1.078e-21 |
5.225e-20 |
97 |
POSITIVE REGULATION OF CELL PROLIFERATION |
57 |
814 |
1.413e-21 |
6.776e-20 |
98 |
CONNECTIVE TISSUE DEVELOPMENT |
30 |
194 |
3.453e-21 |
1.639e-19 |
99 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
52 |
689 |
3.842e-21 |
1.806e-19 |
100 |
CELL SUBSTRATE ADHESION |
28 |
164 |
4.729e-21 |
2.201e-19 |
101 |
MESENCHYME DEVELOPMENT |
29 |
190 |
2.359e-20 |
1.087e-18 |
102 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
67 |
1192 |
3.923e-20 |
1.789e-18 |
103 |
CARTILAGE DEVELOPMENT |
26 |
147 |
4.959e-20 |
2.24e-18 |
104 |
POSITIVE REGULATION OF MAPK CASCADE |
42 |
470 |
7.115e-20 |
3.183e-18 |
105 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
54 |
799 |
9.504e-20 |
4.212e-18 |
106 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
27 |
167 |
1.071e-19 |
4.702e-18 |
107 |
REGULATION OF CELL MORPHOGENESIS |
45 |
552 |
1.158e-19 |
5.036e-18 |
108 |
REGULATION OF GROWTH |
48 |
633 |
1.25e-19 |
5.386e-18 |
109 |
GROWTH |
39 |
410 |
1.855e-19 |
7.919e-18 |
110 |
REGULATION OF IMMUNE SYSTEM PROCESS |
72 |
1403 |
1.952e-19 |
8.258e-18 |
111 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
33 |
285 |
3.362e-19 |
1.409e-17 |
112 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
51 |
740 |
4.956e-19 |
2.059e-17 |
113 |
POSITIVE REGULATION OF CELL ADHESION |
37 |
376 |
5.362e-19 |
2.208e-17 |
114 |
RESPONSE TO STEROID HORMONE |
42 |
497 |
5.698e-19 |
2.326e-17 |
115 |
DEVELOPMENTAL GROWTH |
35 |
333 |
6.175e-19 |
2.498e-17 |
116 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
30 |
232 |
6.503e-19 |
2.609e-17 |
117 |
REGULATION OF VASCULATURE DEVELOPMENT |
30 |
233 |
7.36e-19 |
2.927e-17 |
118 |
HEAD DEVELOPMENT |
49 |
709 |
2.371e-18 |
9.349e-17 |
119 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
56 |
926 |
3.013e-18 |
1.178e-16 |
120 |
EPITHELIAL CELL DIFFERENTIATION |
41 |
495 |
3.192e-18 |
1.238e-16 |
121 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
22 |
112 |
3.704e-18 |
1.424e-16 |
122 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
73 |
1518 |
3.869e-18 |
1.476e-16 |
123 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
43 |
554 |
5.075e-18 |
1.92e-16 |
124 |
EMBRYONIC ORGAN DEVELOPMENT |
37 |
406 |
6.959e-18 |
2.611e-16 |
125 |
REGULATION OF HYDROLASE ACTIVITY |
67 |
1327 |
1.077e-17 |
4.008e-16 |
126 |
EMBRYONIC ORGAN MORPHOGENESIS |
31 |
279 |
1.409e-17 |
5.203e-16 |
127 |
STEM CELL DIFFERENTIATION |
26 |
190 |
3.726e-17 |
1.365e-15 |
128 |
CELL PROLIFERATION |
46 |
672 |
4.219e-17 |
1.534e-15 |
129 |
KIDNEY EPITHELIUM DEVELOPMENT |
22 |
125 |
4.406e-17 |
1.589e-15 |
130 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
28 |
229 |
4.482e-17 |
1.604e-15 |
131 |
MUSCLE STRUCTURE DEVELOPMENT |
37 |
432 |
5.353e-17 |
1.901e-15 |
132 |
OSSIFICATION |
29 |
251 |
5.677e-17 |
2.001e-15 |
133 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
21 |
114 |
8.737e-17 |
3.057e-15 |
134 |
SENSORY ORGAN DEVELOPMENT |
39 |
493 |
1.077e-16 |
3.738e-15 |
135 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
22 |
131 |
1.249e-16 |
4.303e-15 |
136 |
GLAND DEVELOPMENT |
35 |
395 |
1.382e-16 |
4.729e-15 |
137 |
REGULATION OF EPITHELIAL CELL MIGRATION |
24 |
166 |
1.749e-16 |
5.94e-15 |
138 |
SYSTEM PROCESS |
77 |
1785 |
1.764e-16 |
5.948e-15 |
139 |
CELL MATRIX ADHESION |
21 |
119 |
2.189e-16 |
7.326e-15 |
140 |
REGULATION OF CELL ACTIVATION |
38 |
484 |
3.514e-16 |
1.168e-14 |
141 |
CELL ACTIVATION |
41 |
568 |
4.103e-16 |
1.354e-14 |
142 |
RESPONSE TO ALCOHOL |
33 |
362 |
4.675e-16 |
1.532e-14 |
143 |
REGULATION OF RESPONSE TO STRESS |
68 |
1468 |
4.78e-16 |
1.555e-14 |
144 |
HEART MORPHOGENESIS |
26 |
212 |
5.723e-16 |
1.849e-14 |
145 |
POSITIVE REGULATION OF CELL DEATH |
42 |
605 |
6.879e-16 |
2.208e-14 |
146 |
PATTERN SPECIFICATION PROCESS |
35 |
418 |
7.935e-16 |
2.529e-14 |
147 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
38 |
498 |
8.924e-16 |
2.825e-14 |
148 |
IMMUNE SYSTEM DEVELOPMENT |
41 |
582 |
9.514e-16 |
2.991e-14 |
149 |
NEGATIVE REGULATION OF GENE EXPRESSION |
68 |
1493 |
1.113e-15 |
3.476e-14 |
150 |
CELL JUNCTION ASSEMBLY |
21 |
129 |
1.206e-15 |
3.74e-14 |
151 |
REGULATION OF CELLULAR LOCALIZATION |
62 |
1277 |
1.429e-15 |
4.404e-14 |
152 |
SKELETAL SYSTEM MORPHOGENESIS |
25 |
201 |
1.52e-15 |
4.653e-14 |
153 |
NEPHRON DEVELOPMENT |
20 |
115 |
1.548e-15 |
4.709e-14 |
154 |
IMMUNE SYSTEM PROCESS |
80 |
1984 |
1.766e-15 |
5.337e-14 |
155 |
DIGESTIVE SYSTEM DEVELOPMENT |
22 |
148 |
1.801e-15 |
5.407e-14 |
156 |
REGULATION OF KINASE ACTIVITY |
47 |
776 |
2.069e-15 |
6.17e-14 |
157 |
RESPONSE TO OXYGEN LEVELS |
30 |
311 |
2.357e-15 |
6.984e-14 |
158 |
NEURON PROJECTION GUIDANCE |
25 |
205 |
2.426e-15 |
7.145e-14 |
159 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
36 |
465 |
3.453e-15 |
1.01e-13 |
160 |
REGULATION OF TRANSPORT |
75 |
1804 |
3.516e-15 |
1.023e-13 |
161 |
RESPONSE TO NITROGEN COMPOUND |
49 |
859 |
5.04e-15 |
1.457e-13 |
162 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
16 |
67 |
5.61e-15 |
1.611e-13 |
163 |
REGULATION OF CELL CELL ADHESION |
32 |
380 |
1.26e-14 |
3.597e-13 |
164 |
REGULATION OF ORGAN MORPHOGENESIS |
26 |
242 |
1.435e-14 |
4.072e-13 |
165 |
FOREBRAIN DEVELOPMENT |
31 |
357 |
1.449e-14 |
4.085e-13 |
166 |
RESPONSE TO ABIOTIC STIMULUS |
53 |
1024 |
1.809e-14 |
5.069e-13 |
167 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
29 |
312 |
1.854e-14 |
5.165e-13 |
168 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
30 |
337 |
2.038e-14 |
5.645e-13 |
169 |
REGULATION OF RESPONSE TO WOUNDING |
33 |
413 |
2.143e-14 |
5.901e-13 |
170 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
45 |
767 |
2.753e-14 |
7.536e-13 |
171 |
REGULATION OF CELL GROWTH |
32 |
391 |
2.797e-14 |
7.611e-13 |
172 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
66 |
1517 |
2.888e-14 |
7.812e-13 |
173 |
MESENCHYMAL CELL DIFFERENTIATION |
20 |
134 |
3.269e-14 |
8.793e-13 |
174 |
POSITIVE REGULATION OF TRANSPORT |
50 |
936 |
3.311e-14 |
8.855e-13 |
175 |
REGULATION OF HOMEOSTATIC PROCESS |
34 |
447 |
3.558e-14 |
9.461e-13 |
176 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
49 |
905 |
3.72e-14 |
9.835e-13 |
177 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
18 |
103 |
3.794e-14 |
9.918e-13 |
178 |
REGULATION OF NEURON DEATH |
26 |
252 |
3.78e-14 |
9.918e-13 |
179 |
REGULATION OF CARTILAGE DEVELOPMENT |
15 |
63 |
4.227e-14 |
1.099e-12 |
180 |
REGULATION OF INTRACELLULAR TRANSPORT |
40 |
621 |
4.275e-14 |
1.105e-12 |
181 |
MESONEPHROS DEVELOPMENT |
17 |
90 |
5.119e-14 |
1.316e-12 |
182 |
REGULATION OF CYTOPLASMIC TRANSPORT |
35 |
481 |
5.447e-14 |
1.393e-12 |
183 |
REGULATION OF ERK1 AND ERK2 CASCADE |
25 |
238 |
7.899e-14 |
2.008e-12 |
184 |
AGING |
26 |
264 |
1.138e-13 |
2.879e-12 |
185 |
REGULATION OF CHEMOTAXIS |
22 |
180 |
1.15e-13 |
2.892e-12 |
186 |
POSITIVE REGULATION OF CELL ACTIVATION |
28 |
311 |
1.185e-13 |
2.965e-12 |
187 |
REGULATION OF ION HOMEOSTASIS |
23 |
201 |
1.302e-13 |
3.24e-12 |
188 |
HOMEOSTATIC PROCESS |
60 |
1337 |
1.449e-13 |
3.585e-12 |
189 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
34 |
470 |
1.514e-13 |
3.727e-12 |
190 |
INTRACELLULAR SIGNAL TRANSDUCTION |
66 |
1572 |
1.532e-13 |
3.751e-12 |
191 |
POSITIVE REGULATION OF OSSIFICATION |
16 |
84 |
2.504e-13 |
6.099e-12 |
192 |
RESPONSE TO INORGANIC SUBSTANCE |
34 |
479 |
2.603e-13 |
6.309e-12 |
193 |
ADHERENS JUNCTION ORGANIZATION |
15 |
71 |
2.826e-13 |
6.812e-12 |
194 |
POSITIVE REGULATION OF KINASE ACTIVITY |
34 |
482 |
3.11e-13 |
7.459e-12 |
195 |
NEGATIVE REGULATION OF NEURON DEATH |
21 |
171 |
3.837e-13 |
9.156e-12 |
196 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
46 |
867 |
5.105e-13 |
1.212e-11 |
197 |
MUSCLE CELL DIFFERENTIATION |
24 |
237 |
5.65e-13 |
1.334e-11 |
198 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
27 |
307 |
5.804e-13 |
1.364e-11 |
199 |
ARTERY DEVELOPMENT |
15 |
75 |
6.654e-13 |
1.556e-11 |
200 |
RESPONSE TO ESTROGEN |
23 |
218 |
7.358e-13 |
1.712e-11 |
201 |
ENDOTHELIUM DEVELOPMENT |
16 |
90 |
7.726e-13 |
1.789e-11 |
202 |
ARTERY MORPHOGENESIS |
13 |
51 |
8.31e-13 |
1.914e-11 |
203 |
REGULATION OF DEVELOPMENTAL GROWTH |
26 |
289 |
9.405e-13 |
2.156e-11 |
204 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
20 |
162 |
1.278e-12 |
2.915e-11 |
205 |
NEPHRON EPITHELIUM DEVELOPMENT |
16 |
93 |
1.313e-12 |
2.975e-11 |
206 |
RESPONSE TO KETONE |
21 |
182 |
1.317e-12 |
2.975e-11 |
207 |
REGULATION OF MAP KINASE ACTIVITY |
27 |
319 |
1.443e-12 |
3.244e-11 |
208 |
MUSCLE TISSUE DEVELOPMENT |
25 |
275 |
2.076e-12 |
4.644e-11 |
209 |
REGULATION OF CALCIUM ION TRANSPORT |
22 |
209 |
2.468e-12 |
5.494e-11 |
210 |
GLAND MORPHOGENESIS |
16 |
97 |
2.584e-12 |
5.725e-11 |
211 |
PROTEIN PHOSPHORYLATION |
47 |
944 |
2.656e-12 |
5.856e-11 |
212 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
26 |
303 |
2.788e-12 |
6.119e-11 |
213 |
REGULATION OF TRANSFERASE ACTIVITY |
47 |
946 |
2.861e-12 |
6.249e-11 |
214 |
REGULATION OF PROTEIN LOCALIZATION |
47 |
950 |
3.317e-12 |
7.212e-11 |
215 |
LEUKOCYTE MIGRATION |
24 |
259 |
3.868e-12 |
8.37e-11 |
216 |
REGULATION OF WNT SIGNALING PATHWAY |
26 |
310 |
4.69e-12 |
1.01e-10 |
217 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
19 |
154 |
4.777e-12 |
1.024e-10 |
218 |
IN UTERO EMBRYONIC DEVELOPMENT |
26 |
311 |
5.046e-12 |
1.072e-10 |
219 |
REGIONALIZATION |
26 |
311 |
5.046e-12 |
1.072e-10 |
220 |
REGULATION OF BODY FLUID LEVELS |
33 |
506 |
6.042e-12 |
1.278e-10 |
221 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
21 |
197 |
6.171e-12 |
1.299e-10 |
222 |
VASCULOGENESIS |
13 |
59 |
6.306e-12 |
1.322e-10 |
223 |
ACTIN FILAMENT BASED PROCESS |
31 |
450 |
6.791e-12 |
1.411e-10 |
224 |
POSITIVE REGULATION OF CHEMOTAXIS |
17 |
120 |
6.788e-12 |
1.411e-10 |
225 |
LYMPHOCYTE ACTIVATION |
27 |
342 |
7.381e-12 |
1.526e-10 |
226 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
17 |
121 |
7.787e-12 |
1.603e-10 |
227 |
CARDIAC CHAMBER MORPHOGENESIS |
16 |
104 |
7.827e-12 |
1.604e-10 |
228 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
27 |
343 |
7.899e-12 |
1.612e-10 |
229 |
RESPONSE TO ACID CHEMICAL |
26 |
319 |
8.964e-12 |
1.821e-10 |
230 |
BEHAVIOR |
33 |
516 |
1.023e-11 |
2.069e-10 |
231 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
16 |
107 |
1.225e-11 |
2.468e-10 |
232 |
CELL FATE COMMITMENT |
22 |
227 |
1.292e-11 |
2.58e-10 |
233 |
EXTRACELLULAR MATRIX DISASSEMBLY |
14 |
76 |
1.292e-11 |
2.58e-10 |
234 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
34 |
552 |
1.364e-11 |
2.702e-10 |
235 |
REGULATION OF METAL ION TRANSPORT |
26 |
325 |
1.363e-11 |
2.702e-10 |
236 |
CARDIAC CHAMBER DEVELOPMENT |
18 |
144 |
1.409e-11 |
2.777e-10 |
237 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
29 |
408 |
1.578e-11 |
3.099e-10 |
238 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
21 |
207 |
1.6e-11 |
3.128e-10 |
239 |
MUSCLE ORGAN DEVELOPMENT |
24 |
277 |
1.617e-11 |
3.148e-10 |
240 |
EPITHELIAL CELL DEVELOPMENT |
20 |
186 |
1.695e-11 |
3.287e-10 |
241 |
RESPONSE TO MECHANICAL STIMULUS |
21 |
210 |
2.106e-11 |
4.067e-10 |
242 |
REGULATION OF AXONOGENESIS |
19 |
168 |
2.26e-11 |
4.345e-10 |
243 |
REGULATION OF NEURON APOPTOTIC PROCESS |
20 |
192 |
3.039e-11 |
5.82e-10 |
244 |
CELL CELL SIGNALING |
40 |
767 |
3.34e-11 |
6.368e-10 |
245 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
19 |
172 |
3.425e-11 |
6.504e-10 |
246 |
CIRCULATORY SYSTEM PROCESS |
27 |
366 |
3.519e-11 |
6.656e-10 |
247 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
17 |
133 |
3.661e-11 |
6.894e-10 |
248 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
20 |
194 |
3.674e-11 |
6.894e-10 |
249 |
STRIATED MUSCLE CELL DIFFERENTIATION |
19 |
173 |
3.793e-11 |
7.064e-10 |
250 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
14 |
82 |
3.795e-11 |
7.064e-10 |
251 |
GLIOGENESIS |
19 |
175 |
4.642e-11 |
8.606e-10 |
252 |
CELLULAR RESPONSE TO LIPID |
30 |
457 |
4.98e-11 |
9.195e-10 |
253 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
18 |
156 |
5.481e-11 |
1.008e-09 |
254 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
24 |
296 |
6.49e-11 |
1.189e-09 |
255 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
17 |
138 |
6.648e-11 |
1.213e-09 |
256 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
15 |
103 |
8.004e-11 |
1.449e-09 |
257 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
15 |
103 |
8.004e-11 |
1.449e-09 |
258 |
EYE DEVELOPMENT |
25 |
326 |
8.479e-11 |
1.529e-09 |
259 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
9 |
25 |
8.962e-11 |
1.61e-09 |
260 |
ENDOTHELIAL CELL DIFFERENTIATION |
13 |
72 |
9.19e-11 |
1.645e-09 |
261 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
18 |
162 |
1.032e-10 |
1.84e-09 |
262 |
SINGLE ORGANISM BEHAVIOR |
27 |
384 |
1.045e-10 |
1.855e-09 |
263 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
11 |
46 |
1.05e-10 |
1.858e-09 |
264 |
LEUKOCYTE ACTIVATION |
28 |
414 |
1.142e-10 |
2.014e-09 |
265 |
LEUKOCYTE CELL CELL ADHESION |
22 |
255 |
1.262e-10 |
2.216e-09 |
266 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
17 |
144 |
1.316e-10 |
2.302e-09 |
267 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
12 |
60 |
1.396e-10 |
2.433e-09 |
268 |
MUSCLE SYSTEM PROCESS |
23 |
282 |
1.461e-10 |
2.537e-09 |
269 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
32 |
541 |
1.591e-10 |
2.742e-09 |
270 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
32 |
541 |
1.591e-10 |
2.742e-09 |
271 |
DIGESTIVE TRACT MORPHOGENESIS |
11 |
48 |
1.729e-10 |
2.969e-09 |
272 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
28 |
422 |
1.775e-10 |
3.036e-09 |
273 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
21 |
236 |
1.898e-10 |
3.235e-09 |
274 |
MUSCLE CELL DEVELOPMENT |
16 |
128 |
1.957e-10 |
3.323e-09 |
275 |
NEURON MIGRATION |
15 |
110 |
2.087e-10 |
3.531e-09 |
276 |
PHOSPHORYLATION |
51 |
1228 |
2.125e-10 |
3.583e-09 |
277 |
DEVELOPMENTAL MATURATION |
19 |
193 |
2.545e-10 |
4.276e-09 |
278 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
34 |
616 |
2.577e-10 |
4.313e-09 |
279 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
32 |
552 |
2.644e-10 |
4.41e-09 |
280 |
LEUKOCYTE DIFFERENTIATION |
23 |
292 |
2.918e-10 |
4.849e-09 |
281 |
EAR DEVELOPMENT |
19 |
195 |
3.039e-10 |
5.032e-09 |
282 |
OVULATION CYCLE |
15 |
113 |
3.079e-10 |
5.062e-09 |
283 |
REGULATION OF CELL SUBSTRATE ADHESION |
18 |
173 |
3.072e-10 |
5.062e-09 |
284 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
17 |
152 |
3.106e-10 |
5.09e-09 |
285 |
SECRETION |
33 |
588 |
3.145e-10 |
5.134e-09 |
286 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
37 |
724 |
3.435e-10 |
5.589e-09 |
287 |
HOMEOSTASIS OF NUMBER OF CELLS |
18 |
175 |
3.712e-10 |
6.019e-09 |
288 |
REGULATION OF ION TRANSPORT |
33 |
592 |
3.741e-10 |
6.044e-09 |
289 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
15 |
115 |
3.963e-10 |
6.336e-09 |
290 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
28 |
437 |
3.94e-10 |
6.336e-09 |
291 |
CELLULAR RESPONSE TO ALCOHOL |
15 |
115 |
3.963e-10 |
6.336e-09 |
292 |
RESPONSE TO CORTICOSTEROID |
18 |
176 |
4.077e-10 |
6.496e-09 |
293 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
16 |
135 |
4.378e-10 |
6.953e-09 |
294 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
14 |
98 |
4.489e-10 |
7.104e-09 |
295 |
NEGATIVE REGULATION OF CELL ADHESION |
20 |
223 |
4.518e-10 |
7.126e-09 |
296 |
REPRODUCTION |
52 |
1297 |
4.796e-10 |
7.538e-09 |
297 |
GLIAL CELL DIFFERENTIATION |
16 |
136 |
4.892e-10 |
7.664e-09 |
298 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
29 |
472 |
5.025e-10 |
7.82e-09 |
299 |
KIDNEY MORPHOGENESIS |
13 |
82 |
5.019e-10 |
7.82e-09 |
300 |
HINDBRAIN DEVELOPMENT |
16 |
137 |
5.46e-10 |
8.469e-09 |
301 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
30 |
505 |
5.553e-10 |
8.584e-09 |
302 |
CELLULAR CHEMICAL HOMEOSTASIS |
32 |
570 |
5.897e-10 |
9.085e-09 |
303 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
19 |
203 |
6.039e-10 |
9.274e-09 |
304 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
10 |
41 |
6.113e-10 |
9.357e-09 |
305 |
RESPONSE TO METAL ION |
24 |
333 |
7.225e-10 |
1.102e-08 |
306 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
14 |
102 |
7.73e-10 |
1.174e-08 |
307 |
POSITIVE REGULATION OF AXONOGENESIS |
12 |
69 |
7.747e-10 |
1.174e-08 |
308 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
19 |
207 |
8.41e-10 |
1.27e-08 |
309 |
CELL CHEMOTAXIS |
17 |
162 |
8.447e-10 |
1.272e-08 |
310 |
REGULATION OF CALCIUM ION IMPORT |
14 |
103 |
8.82e-10 |
1.324e-08 |
311 |
SECRETION BY CELL |
29 |
486 |
9.87e-10 |
1.476e-08 |
312 |
LYMPHOCYTE DIFFERENTIATION |
19 |
209 |
9.895e-10 |
1.476e-08 |
313 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
14 |
104 |
1.005e-09 |
1.494e-08 |
314 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
27 |
426 |
1.043e-09 |
1.545e-08 |
315 |
NEGATIVE REGULATION OF GROWTH |
20 |
236 |
1.226e-09 |
1.81e-08 |
316 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
21 |
262 |
1.292e-09 |
1.903e-08 |
317 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
22 |
289 |
1.367e-09 |
2.006e-08 |
318 |
POSITIVE REGULATION OF GROWTH |
20 |
238 |
1.42e-09 |
2.072e-08 |
319 |
TRABECULA FORMATION |
8 |
23 |
1.418e-09 |
2.072e-08 |
320 |
REGULATION OF ORGANELLE ORGANIZATION |
48 |
1178 |
1.464e-09 |
2.128e-08 |
321 |
PLATELET DEGRANULATION |
14 |
107 |
1.473e-09 |
2.135e-08 |
322 |
SENSORY ORGAN MORPHOGENESIS |
20 |
239 |
1.528e-09 |
2.208e-08 |
323 |
CHEMICAL HOMEOSTASIS |
40 |
874 |
1.577e-09 |
2.272e-08 |
324 |
ENSHEATHMENT OF NEURONS |
13 |
91 |
1.899e-09 |
2.719e-08 |
325 |
AXON ENSHEATHMENT |
13 |
91 |
1.899e-09 |
2.719e-08 |
326 |
REGULATION OF CYTOSKELETON ORGANIZATION |
29 |
502 |
2.069e-09 |
2.953e-08 |
327 |
FORMATION OF PRIMARY GERM LAYER |
14 |
110 |
2.132e-09 |
3.034e-08 |
328 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
13 |
92 |
2.181e-09 |
3.094e-08 |
329 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
32 |
602 |
2.26e-09 |
3.196e-08 |
330 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
45 |
1079 |
2.506e-09 |
3.533e-08 |
331 |
CELLULAR HOMEOSTASIS |
34 |
676 |
2.834e-09 |
3.984e-08 |
332 |
REGULATION OF BMP SIGNALING PATHWAY |
12 |
77 |
2.885e-09 |
4.043e-08 |
333 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
21 |
274 |
2.895e-09 |
4.045e-08 |
334 |
REGULATED EXOCYTOSIS |
19 |
224 |
3.161e-09 |
4.404e-08 |
335 |
FOREBRAIN CELL MIGRATION |
11 |
62 |
3.196e-09 |
4.425e-08 |
336 |
CARDIAC VENTRICLE MORPHOGENESIS |
11 |
62 |
3.196e-09 |
4.425e-08 |
337 |
RENAL TUBULE DEVELOPMENT |
12 |
78 |
3.362e-09 |
4.642e-08 |
338 |
BONE DEVELOPMENT |
16 |
156 |
3.735e-09 |
5.142e-08 |
339 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
21 |
278 |
3.751e-09 |
5.148e-08 |
340 |
CELL GROWTH |
15 |
135 |
3.828e-09 |
5.239e-08 |
341 |
TELENCEPHALON DEVELOPMENT |
19 |
228 |
4.239e-09 |
5.785e-08 |
342 |
REGULATION OF DEFENSE RESPONSE |
36 |
759 |
4.416e-09 |
6.007e-08 |
343 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
12 |
80 |
4.534e-09 |
6.151e-08 |
344 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
21 |
282 |
4.837e-09 |
6.543e-08 |
345 |
REGULATION OF BINDING |
21 |
283 |
5.151e-09 |
6.947e-08 |
346 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
12 |
81 |
5.248e-09 |
7.057e-08 |
347 |
HEMOSTASIS |
22 |
311 |
5.327e-09 |
7.143e-08 |
348 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
24 |
370 |
5.836e-09 |
7.802e-08 |
349 |
REGENERATION |
16 |
161 |
5.912e-09 |
7.883e-08 |
350 |
RESPONSE TO DRUG |
26 |
431 |
6.028e-09 |
8.014e-08 |
351 |
CELLULAR MACROMOLECULE LOCALIZATION |
48 |
1234 |
6.53e-09 |
8.656e-08 |
352 |
PEPTIDYL TYROSINE MODIFICATION |
17 |
186 |
7.058e-09 |
9.329e-08 |
353 |
TRABECULA MORPHOGENESIS |
9 |
39 |
7.654e-09 |
1.006e-07 |
354 |
REGULATION OF GRANULOCYTE CHEMOTAXIS |
9 |
39 |
7.654e-09 |
1.006e-07 |
355 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
25 |
406 |
7.936e-09 |
1.04e-07 |
356 |
REGULATION OF GTPASE ACTIVITY |
33 |
673 |
9.165e-09 |
1.198e-07 |
357 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
44 |
1087 |
9.424e-09 |
1.228e-07 |
358 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
17 |
190 |
9.731e-09 |
1.265e-07 |
359 |
KIDNEY VASCULATURE DEVELOPMENT |
7 |
19 |
9.85e-09 |
1.273e-07 |
360 |
RENAL SYSTEM VASCULATURE DEVELOPMENT |
7 |
19 |
9.85e-09 |
1.273e-07 |
361 |
REGULATION OF IMMUNE RESPONSE |
38 |
858 |
1.019e-08 |
1.314e-07 |
362 |
NEGATIVE REGULATION OF OSSIFICATION |
11 |
69 |
1.039e-08 |
1.336e-07 |
363 |
REGULATION OF SYSTEM PROCESS |
28 |
507 |
1.059e-08 |
1.357e-07 |
364 |
RESPONSE TO ESTRADIOL |
15 |
146 |
1.129e-08 |
1.444e-07 |
365 |
POSITIVE REGULATION OF CELL CELL ADHESION |
19 |
243 |
1.206e-08 |
1.538e-07 |
366 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
11 |
70 |
1.216e-08 |
1.546e-07 |
367 |
SPINAL CORD DEVELOPMENT |
13 |
106 |
1.275e-08 |
1.608e-07 |
368 |
REGULATION OF WOUND HEALING |
14 |
126 |
1.275e-08 |
1.608e-07 |
369 |
CARDIAC VENTRICLE DEVELOPMENT |
13 |
106 |
1.275e-08 |
1.608e-07 |
370 |
NEGATIVE REGULATION OF CELL GROWTH |
16 |
170 |
1.296e-08 |
1.629e-07 |
371 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
33 |
684 |
1.357e-08 |
1.702e-07 |
372 |
REGULATION OF STEM CELL PROLIFERATION |
12 |
88 |
1.381e-08 |
1.727e-07 |
373 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
18 |
220 |
1.456e-08 |
1.816e-07 |
374 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
31 |
616 |
1.464e-08 |
1.822e-07 |
375 |
REGULATION OF LEUKOCYTE MIGRATION |
15 |
149 |
1.491e-08 |
1.85e-07 |
376 |
MODULATION OF SYNAPTIC TRANSMISSION |
21 |
301 |
1.525e-08 |
1.887e-07 |
377 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
9 |
42 |
1.545e-08 |
1.907e-07 |
378 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
10 |
56 |
1.574e-08 |
1.938e-07 |
379 |
RESPIRATORY SYSTEM DEVELOPMENT |
17 |
197 |
1.674e-08 |
2.055e-07 |
380 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
15 |
152 |
1.956e-08 |
2.395e-07 |
381 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
14 |
131 |
2.11e-08 |
2.577e-07 |
382 |
AMEBOIDAL TYPE CELL MIGRATION |
15 |
154 |
2.336e-08 |
2.837e-07 |
383 |
PROTEIN LOCALIZATION |
60 |
1805 |
2.33e-08 |
2.837e-07 |
384 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
26 |
462 |
2.488e-08 |
3.015e-07 |
385 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
11 |
75 |
2.566e-08 |
3.077e-07 |
386 |
GASTRULATION |
15 |
155 |
2.549e-08 |
3.077e-07 |
387 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
11 |
75 |
2.566e-08 |
3.077e-07 |
388 |
NEURAL CREST CELL DIFFERENTIATION |
11 |
75 |
2.566e-08 |
3.077e-07 |
389 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
12 |
93 |
2.61e-08 |
3.122e-07 |
390 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
8 |
32 |
2.689e-08 |
3.199e-07 |
391 |
REGULATION OF NEUTROPHIL MIGRATION |
8 |
32 |
2.689e-08 |
3.199e-07 |
392 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
17 |
204 |
2.813e-08 |
3.339e-07 |
393 |
SPROUTING ANGIOGENESIS |
9 |
45 |
2.945e-08 |
3.487e-07 |
394 |
CHONDROCYTE DIFFERENTIATION |
10 |
60 |
3.153e-08 |
3.723e-07 |
395 |
REGULATION OF HEMOPOIESIS |
21 |
314 |
3.173e-08 |
3.738e-07 |
396 |
MUSCLE CONTRACTION |
18 |
233 |
3.542e-08 |
4.162e-07 |
397 |
REGULATION OF PROTEIN IMPORT |
16 |
183 |
3.694e-08 |
4.329e-07 |
398 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
12 |
96 |
3.752e-08 |
4.387e-07 |
399 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
13 |
116 |
3.828e-08 |
4.464e-07 |
400 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
29 |
573 |
3.885e-08 |
4.52e-07 |
401 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
16 |
184 |
3.988e-08 |
4.628e-07 |
402 |
RESPONSE TO FLUID SHEAR STRESS |
8 |
34 |
4.515e-08 |
5.226e-07 |
403 |
WNT SIGNALING PATHWAY |
22 |
351 |
4.716e-08 |
5.431e-07 |
404 |
MESODERM DEVELOPMENT |
13 |
118 |
4.705e-08 |
5.431e-07 |
405 |
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION |
12 |
98 |
4.744e-08 |
5.45e-07 |
406 |
REGULATION OF SYNAPTIC PLASTICITY |
14 |
140 |
4.94e-08 |
5.661e-07 |
407 |
RESPONSE TO OXIDATIVE STRESS |
22 |
352 |
4.959e-08 |
5.669e-07 |
408 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
17 |
213 |
5.312e-08 |
6.058e-07 |
409 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
9 |
48 |
5.346e-08 |
6.082e-07 |
410 |
CYTOSKELETON ORGANIZATION |
36 |
838 |
5.545e-08 |
6.293e-07 |
411 |
METANEPHROS DEVELOPMENT |
11 |
81 |
5.838e-08 |
6.61e-07 |
412 |
METENCEPHALON DEVELOPMENT |
12 |
100 |
5.964e-08 |
6.735e-07 |
413 |
REGULATION OF PROTEIN KINASE B SIGNALING |
13 |
121 |
6.362e-08 |
7.167e-07 |
414 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
15 |
166 |
6.398e-08 |
7.191e-07 |
415 |
GLOMERULUS DEVELOPMENT |
9 |
49 |
6.459e-08 |
7.242e-07 |
416 |
RESPONSE TO NUTRIENT |
16 |
191 |
6.73e-08 |
7.528e-07 |
417 |
CELL DEATH |
40 |
1001 |
6.767e-08 |
7.551e-07 |
418 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
13 |
122 |
7.021e-08 |
7.815e-07 |
419 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
17 |
218 |
7.454e-08 |
8.278e-07 |
420 |
REGULATION OF PEPTIDASE ACTIVITY |
23 |
392 |
7.746e-08 |
8.582e-07 |
421 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
9 |
50 |
7.768e-08 |
8.586e-07 |
422 |
NEGATIVE REGULATION OF TRANSPORT |
25 |
458 |
8.407e-08 |
9.269e-07 |
423 |
INOSITOL LIPID MEDIATED SIGNALING |
13 |
124 |
8.525e-08 |
9.378e-07 |
424 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
11 |
84 |
8.576e-08 |
9.389e-07 |
425 |
TISSUE MIGRATION |
11 |
84 |
8.576e-08 |
9.389e-07 |
426 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
9 |
51 |
9.303e-08 |
1.016e-06 |
427 |
CEREBRAL CORTEX DEVELOPMENT |
12 |
105 |
1.033e-07 |
1.125e-06 |
428 |
REGULATION OF PROTEIN TARGETING |
20 |
307 |
1.044e-07 |
1.135e-06 |
429 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
12 |
106 |
1.148e-07 |
1.243e-06 |
430 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
8 |
38 |
1.151e-07 |
1.243e-06 |
431 |
MESENCHYME MORPHOGENESIS |
8 |
38 |
1.151e-07 |
1.243e-06 |
432 |
REGULATION OF ENDOCYTOSIS |
16 |
199 |
1.19e-07 |
1.281e-06 |
433 |
EXOCYTOSIS |
20 |
310 |
1.223e-07 |
1.314e-06 |
434 |
REGULATION OF LIPID METABOLIC PROCESS |
19 |
282 |
1.297e-07 |
1.391e-06 |
435 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
22 |
372 |
1.305e-07 |
1.396e-06 |
436 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
9 |
53 |
1.318e-07 |
1.403e-06 |
437 |
MESONEPHRIC TUBULE MORPHOGENESIS |
9 |
53 |
1.318e-07 |
1.403e-06 |
438 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
22 |
375 |
1.5e-07 |
1.593e-06 |
439 |
PALLIUM DEVELOPMENT |
14 |
153 |
1.511e-07 |
1.601e-06 |
440 |
ION HOMEOSTASIS |
28 |
576 |
1.551e-07 |
1.641e-06 |
441 |
POSITIVE REGULATION OF CALCIUM ION IMPORT |
9 |
54 |
1.56e-07 |
1.642e-06 |
442 |
REGULATION OF NEUTROPHIL CHEMOTAXIS |
7 |
27 |
1.557e-07 |
1.642e-06 |
443 |
CELL MATURATION |
13 |
131 |
1.635e-07 |
1.717e-06 |
444 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
12 |
110 |
1.735e-07 |
1.818e-06 |
445 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
8 |
40 |
1.761e-07 |
1.841e-06 |
446 |
PEPTIDYL AMINO ACID MODIFICATION |
35 |
841 |
1.846e-07 |
1.926e-06 |
447 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
14 |
156 |
1.924e-07 |
2.002e-06 |
448 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
22 |
381 |
1.972e-07 |
2.048e-06 |
449 |
AORTA DEVELOPMENT |
8 |
41 |
2.158e-07 |
2.226e-06 |
450 |
EMBRYONIC HEART TUBE DEVELOPMENT |
10 |
73 |
2.167e-07 |
2.226e-06 |
451 |
REGULATION OF ORGAN GROWTH |
10 |
73 |
2.167e-07 |
2.226e-06 |
452 |
OUTFLOW TRACT MORPHOGENESIS |
9 |
56 |
2.162e-07 |
2.226e-06 |
453 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
10 |
73 |
2.167e-07 |
2.226e-06 |
454 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
16 |
208 |
2.184e-07 |
2.238e-06 |
455 |
POSITIVE REGULATION OF ION TRANSPORT |
17 |
236 |
2.337e-07 |
2.39e-06 |
456 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
6 |
18 |
2.347e-07 |
2.395e-06 |
457 |
REGULATION OF JNK CASCADE |
14 |
159 |
2.435e-07 |
2.48e-06 |
458 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
10 |
74 |
2.471e-07 |
2.505e-06 |
459 |
CELL CELL JUNCTION ASSEMBLY |
10 |
74 |
2.471e-07 |
2.505e-06 |
460 |
REGULATION OF INFLAMMATORY RESPONSE |
19 |
294 |
2.477e-07 |
2.505e-06 |
461 |
POSITIVE REGULATION OF ENDOCYTOSIS |
12 |
114 |
2.575e-07 |
2.599e-06 |
462 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
8 |
42 |
2.63e-07 |
2.649e-06 |
463 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
7 |
29 |
2.664e-07 |
2.677e-06 |
464 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
13 |
137 |
2.764e-07 |
2.761e-06 |
465 |
INFLAMMATORY RESPONSE |
24 |
454 |
2.764e-07 |
2.761e-06 |
466 |
RESPONSE TO BMP |
11 |
94 |
2.771e-07 |
2.761e-06 |
467 |
CELLULAR RESPONSE TO BMP STIMULUS |
11 |
94 |
2.771e-07 |
2.761e-06 |
468 |
MULTI MULTICELLULAR ORGANISM PROCESS |
16 |
213 |
3.017e-07 |
3e-06 |
469 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
14 |
162 |
3.067e-07 |
3.042e-06 |
470 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
12 |
116 |
3.118e-07 |
3.086e-06 |
471 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
21 |
360 |
3.18e-07 |
3.142e-06 |
472 |
REGULATION OF CELL SHAPE |
13 |
139 |
3.273e-07 |
3.227e-06 |
473 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
7 |
30 |
3.428e-07 |
3.358e-06 |
474 |
ESTABLISHMENT OF ENDOTHELIAL BARRIER |
7 |
30 |
3.428e-07 |
3.358e-06 |
475 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
7 |
30 |
3.428e-07 |
3.358e-06 |
476 |
CARDIOCYTE DIFFERENTIATION |
11 |
96 |
3.441e-07 |
3.364e-06 |
477 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
10 |
77 |
3.619e-07 |
3.53e-06 |
478 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
34 |
829 |
3.922e-07 |
3.818e-06 |
479 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
15 |
191 |
4.018e-07 |
3.903e-06 |
480 |
SOMITE DEVELOPMENT |
10 |
78 |
4.093e-07 |
3.968e-06 |
481 |
PLATELET ACTIVATION |
13 |
142 |
4.194e-07 |
4.057e-06 |
482 |
ENDOTHELIAL CELL DEVELOPMENT |
8 |
45 |
4.609e-07 |
4.449e-06 |
483 |
REGULATION OF CELLULAR COMPONENT SIZE |
20 |
337 |
4.656e-07 |
4.485e-06 |
484 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
11 |
99 |
4.716e-07 |
4.515e-06 |
485 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
11 |
99 |
4.716e-07 |
4.515e-06 |
486 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
11 |
99 |
4.716e-07 |
4.515e-06 |
487 |
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION |
6 |
20 |
4.772e-07 |
4.55e-06 |
488 |
LYMPH VESSEL DEVELOPMENT |
6 |
20 |
4.772e-07 |
4.55e-06 |
489 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
13 |
144 |
4.93e-07 |
4.691e-06 |
490 |
ADULT LOCOMOTORY BEHAVIOR |
10 |
80 |
5.209e-07 |
4.946e-06 |
491 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
9 |
62 |
5.327e-07 |
5.038e-06 |
492 |
EMBRYONIC HEART TUBE MORPHOGENESIS |
9 |
62 |
5.327e-07 |
5.038e-06 |
493 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
22 |
404 |
5.349e-07 |
5.048e-06 |
494 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
12 |
122 |
5.407e-07 |
5.093e-06 |
495 |
PATTERNING OF BLOOD VESSELS |
7 |
32 |
5.515e-07 |
5.184e-06 |
496 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
60 |
1977 |
5.57e-07 |
5.225e-06 |
497 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
15 |
197 |
5.974e-07 |
5.593e-06 |
498 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
30 |
691 |
6.141e-07 |
5.738e-06 |
499 |
RESPONSE TO EXTRACELLULAR STIMULUS |
23 |
441 |
6.234e-07 |
5.813e-06 |
500 |
REGULATION OF CATABOLIC PROCESS |
31 |
731 |
6.524e-07 |
6.072e-06 |
501 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
5 |
12 |
6.899e-07 |
6.408e-06 |
502 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
9 |
64 |
7.034e-07 |
6.52e-06 |
503 |
NEURAL TUBE DEVELOPMENT |
13 |
149 |
7.299e-07 |
6.752e-06 |
504 |
OSTEOBLAST DIFFERENTIATION |
12 |
126 |
7.667e-07 |
7.079e-06 |
505 |
REGULATION OF LIPID KINASE ACTIVITY |
8 |
48 |
7.743e-07 |
7.134e-06 |
506 |
REGULATION OF SECRETION |
30 |
699 |
7.799e-07 |
7.172e-06 |
507 |
CELLULAR RESPONSE TO ACID CHEMICAL |
14 |
175 |
7.858e-07 |
7.183e-06 |
508 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
14 |
175 |
7.858e-07 |
7.183e-06 |
509 |
IMMUNE RESPONSE |
40 |
1100 |
7.829e-07 |
7.183e-06 |
510 |
POSITIVE REGULATION OF BINDING |
12 |
127 |
8.349e-07 |
7.617e-06 |
511 |
ADHERENS JUNCTION ASSEMBLY |
7 |
34 |
8.579e-07 |
7.767e-06 |
512 |
RESPONSE TO PROSTAGLANDIN |
7 |
34 |
8.579e-07 |
7.767e-06 |
513 |
HEART VALVE DEVELOPMENT |
7 |
34 |
8.579e-07 |
7.767e-06 |
514 |
ODONTOGENESIS |
11 |
105 |
8.571e-07 |
7.767e-06 |
515 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
6 |
22 |
8.944e-07 |
8.066e-06 |
516 |
AORTA MORPHOGENESIS |
6 |
22 |
8.944e-07 |
8.066e-06 |
517 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
8 |
49 |
9.128e-07 |
8.215e-06 |
518 |
REGULATION OF CHROMATIN ORGANIZATION |
13 |
152 |
9.166e-07 |
8.234e-06 |
519 |
REGULATION OF FAT CELL DIFFERENTIATION |
11 |
106 |
9.43e-07 |
8.438e-06 |
520 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
19 |
321 |
9.421e-07 |
8.438e-06 |
521 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
16 |
232 |
9.489e-07 |
8.459e-06 |
522 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
16 |
232 |
9.489e-07 |
8.459e-06 |
523 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
13 |
153 |
9.877e-07 |
8.788e-06 |
524 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
16 |
233 |
1.005e-06 |
8.92e-06 |
525 |
POSITIVE REGULATION OF PEPTIDASE ACTIVITY |
13 |
154 |
1.064e-06 |
9.427e-06 |
526 |
RESPONSE TO PROGESTERONE |
8 |
50 |
1.072e-06 |
9.482e-06 |
527 |
LYMPH VESSEL MORPHOGENESIS |
5 |
13 |
1.107e-06 |
9.743e-06 |
528 |
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS |
5 |
13 |
1.107e-06 |
9.743e-06 |
529 |
REGULATION OF PROTEOLYSIS |
30 |
711 |
1.108e-06 |
9.743e-06 |
530 |
TISSUE REMODELING |
10 |
87 |
1.148e-06 |
1.008e-05 |
531 |
LOCOMOTORY BEHAVIOR |
14 |
181 |
1.178e-06 |
1.033e-05 |
532 |
REGULATION OF CELL JUNCTION ASSEMBLY |
9 |
68 |
1.191e-06 |
1.04e-05 |
533 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
9 |
68 |
1.191e-06 |
1.04e-05 |
534 |
SEX DIFFERENTIATION |
17 |
266 |
1.249e-06 |
1.088e-05 |
535 |
OVULATION CYCLE PROCESS |
10 |
88 |
1.277e-06 |
1.111e-05 |
536 |
POSITIVE REGULATION OF AXON EXTENSION |
7 |
36 |
1.296e-06 |
1.125e-05 |
537 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
20 |
364 |
1.546e-06 |
1.34e-05 |
538 |
FOCAL ADHESION ASSEMBLY |
6 |
24 |
1.571e-06 |
1.354e-05 |
539 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
6 |
24 |
1.571e-06 |
1.354e-05 |
540 |
CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY |
6 |
24 |
1.571e-06 |
1.354e-05 |
541 |
REGULATION OF CELL MATRIX ADHESION |
10 |
90 |
1.575e-06 |
1.354e-05 |
542 |
ADULT BEHAVIOR |
12 |
135 |
1.605e-06 |
1.378e-05 |
543 |
EAR MORPHOGENESIS |
11 |
112 |
1.637e-06 |
1.403e-05 |
544 |
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT |
5 |
14 |
1.699e-06 |
1.44e-05 |
545 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
5 |
14 |
1.699e-06 |
1.44e-05 |
546 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
8 |
53 |
1.698e-06 |
1.44e-05 |
547 |
HEART TRABECULA FORMATION |
5 |
14 |
1.699e-06 |
1.44e-05 |
548 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
5 |
14 |
1.699e-06 |
1.44e-05 |
549 |
CELLULAR RESPONSE TO VITAMIN D |
5 |
14 |
1.699e-06 |
1.44e-05 |
550 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
13 |
162 |
1.885e-06 |
1.594e-05 |
551 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
7 |
38 |
1.907e-06 |
1.61e-05 |
552 |
MYELOID CELL DIFFERENTIATION |
14 |
189 |
1.972e-06 |
1.662e-05 |
553 |
POSITIVE REGULATION OF HEMOPOIESIS |
13 |
163 |
2.019e-06 |
1.696e-05 |
554 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
13 |
163 |
2.019e-06 |
1.696e-05 |
555 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
12 |
138 |
2.025e-06 |
1.698e-05 |
556 |
RESPONSE TO PROSTAGLANDIN E |
6 |
25 |
2.04e-06 |
1.707e-05 |
557 |
RESPONSE TO PEPTIDE |
21 |
404 |
2.044e-06 |
1.708e-05 |
558 |
CELLULAR RESPONSE TO KETONE |
9 |
73 |
2.189e-06 |
1.826e-05 |
559 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
14 |
191 |
2.233e-06 |
1.859e-05 |
560 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
8 |
55 |
2.27e-06 |
1.886e-05 |
561 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
7 |
39 |
2.292e-06 |
1.891e-05 |
562 |
LONG TERM SYNAPTIC POTENTIATION |
7 |
39 |
2.292e-06 |
1.891e-05 |
563 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
7 |
39 |
2.292e-06 |
1.891e-05 |
564 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
7 |
39 |
2.292e-06 |
1.891e-05 |
565 |
FEMALE SEX DIFFERENTIATION |
11 |
116 |
2.318e-06 |
1.909e-05 |
566 |
VESICLE MEDIATED TRANSPORT |
42 |
1239 |
2.472e-06 |
2.032e-05 |
567 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
5 |
15 |
2.516e-06 |
2.065e-05 |
568 |
MAMMARY GLAND DEVELOPMENT |
11 |
117 |
2.523e-06 |
2.067e-05 |
569 |
REGULATION OF HEART CONTRACTION |
15 |
221 |
2.534e-06 |
2.072e-05 |
570 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
10 |
95 |
2.594e-06 |
2.118e-05 |
571 |
HEART TRABECULA MORPHOGENESIS |
6 |
26 |
2.617e-06 |
2.125e-05 |
572 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
8 |
56 |
2.612e-06 |
2.125e-05 |
573 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
6 |
26 |
2.617e-06 |
2.125e-05 |
574 |
COGNITION |
16 |
251 |
2.66e-06 |
2.156e-05 |
575 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
7 |
40 |
2.741e-06 |
2.218e-05 |
576 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
12 |
143 |
2.946e-06 |
2.38e-05 |
577 |
PROSTATE GLAND DEVELOPMENT |
7 |
41 |
3.261e-06 |
2.63e-05 |
578 |
POSITIVE REGULATION OF NEUTROPHIL MIGRATION |
6 |
27 |
3.32e-06 |
2.659e-05 |
579 |
SUBSTRATE DEPENDENT CELL MIGRATION |
6 |
27 |
3.32e-06 |
2.659e-05 |
580 |
AXIS ELONGATION |
6 |
27 |
3.32e-06 |
2.659e-05 |
581 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
6 |
27 |
3.32e-06 |
2.659e-05 |
582 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
9 |
77 |
3.443e-06 |
2.748e-05 |
583 |
DEVELOPMENTAL CELL GROWTH |
9 |
77 |
3.443e-06 |
2.748e-05 |
584 |
RESPONSE TO VITAMIN |
10 |
98 |
3.449e-06 |
2.748e-05 |
585 |
EXTRACELLULAR MATRIX ASSEMBLY |
5 |
16 |
3.612e-06 |
2.873e-05 |
586 |
REGULATION OF CYTOKINE PRODUCTION |
25 |
563 |
3.724e-06 |
2.957e-05 |
587 |
MYELOID LEUKOCYTE MIGRATION |
10 |
99 |
3.783e-06 |
2.994e-05 |
588 |
LIPID PHOSPHORYLATION |
10 |
99 |
3.783e-06 |
2.994e-05 |
589 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
7 |
42 |
3.861e-06 |
3.045e-05 |
590 |
REGULATION OF HEART GROWTH |
7 |
42 |
3.861e-06 |
3.045e-05 |
591 |
T CELL DIFFERENTIATION |
11 |
123 |
4.121e-06 |
3.245e-05 |
592 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
10 |
100 |
4.146e-06 |
3.258e-05 |
593 |
POSITIVE REGULATION OF CELL GROWTH |
12 |
148 |
4.216e-06 |
3.308e-05 |
594 |
REGULATION OF PROTEIN SECRETION |
20 |
389 |
4.234e-06 |
3.317e-05 |
595 |
DENDRITE DEVELOPMENT |
9 |
79 |
4.272e-06 |
3.341e-05 |
596 |
STEM CELL PROLIFERATION |
8 |
60 |
4.454e-06 |
3.476e-05 |
597 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
11 |
124 |
4.459e-06 |
3.476e-05 |
598 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
7 |
43 |
4.55e-06 |
3.54e-05 |
599 |
RESPONSE TO BIOTIC STIMULUS |
33 |
886 |
4.736e-06 |
3.679e-05 |
600 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
20 |
393 |
4.933e-06 |
3.826e-05 |
601 |
EMBRYONIC DIGIT MORPHOGENESIS |
8 |
61 |
5.057e-06 |
3.894e-05 |
602 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
8 |
61 |
5.057e-06 |
3.894e-05 |
603 |
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
5 |
17 |
5.051e-06 |
3.894e-05 |
604 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
5 |
17 |
5.051e-06 |
3.894e-05 |
605 |
REGULATION OF BLOOD CIRCULATION |
17 |
295 |
5.063e-06 |
3.894e-05 |
606 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
16 |
264 |
5.086e-06 |
3.905e-05 |
607 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
6 |
29 |
5.188e-06 |
3.977e-05 |
608 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
7 |
44 |
5.338e-06 |
4.085e-05 |
609 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
13 |
179 |
5.695e-06 |
4.351e-05 |
610 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
20 |
397 |
5.735e-06 |
4.375e-05 |
611 |
RHYTHMIC PROCESS |
17 |
298 |
5.79e-06 |
4.41e-05 |
612 |
POSITIVE REGULATION OF PROTEIN IMPORT |
10 |
104 |
5.913e-06 |
4.495e-05 |
613 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
11 |
128 |
6.068e-06 |
4.606e-05 |
614 |
EXOCRINE SYSTEM DEVELOPMENT |
7 |
45 |
6.236e-06 |
4.726e-05 |
615 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
6 |
30 |
6.399e-06 |
4.841e-05 |
616 |
REGULATION OF LIPASE ACTIVITY |
9 |
83 |
6.456e-06 |
4.869e-05 |
617 |
RESPONSE TO FATTY ACID |
9 |
83 |
6.456e-06 |
4.869e-05 |
618 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
11 |
129 |
6.542e-06 |
4.925e-05 |
619 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
5 |
18 |
6.903e-06 |
5.189e-05 |
620 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
12 |
156 |
7.261e-06 |
5.44e-05 |
621 |
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
12 |
156 |
7.261e-06 |
5.44e-05 |
622 |
REGULATION OF PROTEIN ACETYLATION |
8 |
64 |
7.295e-06 |
5.457e-05 |
623 |
RESPONSE TO RETINOIC ACID |
10 |
107 |
7.635e-06 |
5.702e-05 |
624 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
23 |
514 |
8.122e-06 |
6.056e-05 |
625 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
11 |
132 |
8.161e-06 |
6.076e-05 |
626 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
7 |
47 |
8.412e-06 |
6.252e-05 |
627 |
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY |
15 |
245 |
8.892e-06 |
6.599e-05 |
628 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
10 |
109 |
9.01e-06 |
6.665e-05 |
629 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
10 |
109 |
9.01e-06 |
6.665e-05 |
630 |
FOREBRAIN GENERATION OF NEURONS |
8 |
66 |
9.211e-06 |
6.792e-05 |
631 |
MESODERM MORPHOGENESIS |
8 |
66 |
9.211e-06 |
6.792e-05 |
632 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
5 |
19 |
9.248e-06 |
6.798e-05 |
633 |
FIBRIL ORGANIZATION |
5 |
19 |
9.248e-06 |
6.798e-05 |
634 |
SALIVARY GLAND DEVELOPMENT |
6 |
32 |
9.509e-06 |
6.946e-05 |
635 |
ENDOCARDIAL CUSHION DEVELOPMENT |
6 |
32 |
9.509e-06 |
6.946e-05 |
636 |
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION |
6 |
32 |
9.509e-06 |
6.946e-05 |
637 |
METANEPHRIC NEPHRON DEVELOPMENT |
6 |
32 |
9.509e-06 |
6.946e-05 |
638 |
MYOFIBRIL ASSEMBLY |
7 |
48 |
9.716e-06 |
7.075e-05 |
639 |
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
7 |
48 |
9.716e-06 |
7.075e-05 |
640 |
REGULATION OF MEMBRANE POTENTIAL |
18 |
343 |
9.733e-06 |
7.076e-05 |
641 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
14 |
218 |
1.033e-05 |
7.497e-05 |
642 |
REGULATION OF COAGULATION |
9 |
88 |
1.047e-05 |
7.58e-05 |
643 |
ESTABLISHMENT OF CELL POLARITY |
9 |
88 |
1.047e-05 |
7.58e-05 |
644 |
RESPONSE TO ETHANOL |
11 |
136 |
1.086e-05 |
7.845e-05 |
645 |
CARDIAC CELL DEVELOPMENT |
7 |
49 |
1.118e-05 |
8.067e-05 |
646 |
RESPONSE TO VITAMIN D |
6 |
33 |
1.147e-05 |
8.261e-05 |
647 |
SEGMENTATION |
9 |
89 |
1.149e-05 |
8.266e-05 |
648 |
ORGAN GROWTH |
8 |
68 |
1.153e-05 |
8.282e-05 |
649 |
REGULATION OF GLIOGENESIS |
9 |
90 |
1.26e-05 |
9.03e-05 |
650 |
RECEPTOR INTERNALIZATION |
7 |
50 |
1.283e-05 |
9.17e-05 |
651 |
ENDODERM FORMATION |
7 |
50 |
1.283e-05 |
9.17e-05 |
652 |
CALCIUM ION TRANSPORT |
14 |
223 |
1.335e-05 |
9.527e-05 |
653 |
FOREBRAIN NEURON DEVELOPMENT |
6 |
34 |
1.374e-05 |
9.778e-05 |
654 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
6 |
34 |
1.374e-05 |
9.778e-05 |
655 |
MULTICELLULAR ORGANISM REPRODUCTION |
29 |
768 |
1.426e-05 |
0.0001013 |
656 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
11 |
140 |
1.43e-05 |
0.0001014 |
657 |
NEGATIVE REGULATION OF CHEMOTAXIS |
7 |
51 |
1.467e-05 |
0.0001039 |
658 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
20 |
424 |
1.503e-05 |
0.0001063 |
659 |
INNER EAR MORPHOGENESIS |
9 |
92 |
1.507e-05 |
0.0001064 |
660 |
METANEPHRIC NEPHRON MORPHOGENESIS |
5 |
21 |
1.577e-05 |
0.0001105 |
661 |
CELL AGGREGATION |
5 |
21 |
1.577e-05 |
0.0001105 |
662 |
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT |
5 |
21 |
1.577e-05 |
0.0001105 |
663 |
CARTILAGE CONDENSATION |
5 |
21 |
1.577e-05 |
0.0001105 |
664 |
RESPONSE TO NITRIC OXIDE |
5 |
21 |
1.577e-05 |
0.0001105 |
665 |
ENDODERM DEVELOPMENT |
8 |
71 |
1.593e-05 |
0.0001113 |
666 |
CELL FATE SPECIFICATION |
8 |
71 |
1.593e-05 |
0.0001113 |
667 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
13 |
197 |
1.601e-05 |
0.0001117 |
668 |
REGULATION OF BLOOD PRESSURE |
12 |
169 |
1.636e-05 |
0.0001136 |
669 |
APPENDAGE DEVELOPMENT |
12 |
169 |
1.636e-05 |
0.0001136 |
670 |
LIMB DEVELOPMENT |
12 |
169 |
1.636e-05 |
0.0001136 |
671 |
REGULATION OF DNA BINDING |
9 |
93 |
1.646e-05 |
0.0001141 |
672 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
7 |
52 |
1.673e-05 |
0.0001158 |
673 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
10 |
117 |
1.687e-05 |
0.0001164 |
674 |
SPECIFICATION OF SYMMETRY |
10 |
117 |
1.687e-05 |
0.0001164 |
675 |
RAS PROTEIN SIGNAL TRANSDUCTION |
11 |
143 |
1.746e-05 |
0.0001204 |
676 |
SMOOTHENED SIGNALING PATHWAY |
8 |
72 |
1.768e-05 |
0.0001217 |
677 |
LYMPHANGIOGENESIS |
4 |
11 |
1.849e-05 |
0.0001269 |
678 |
OLFACTORY BULB INTERNEURON DEVELOPMENT |
4 |
11 |
1.849e-05 |
0.0001269 |
679 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
7 |
53 |
1.901e-05 |
0.0001299 |
680 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
7 |
53 |
1.901e-05 |
0.0001299 |
681 |
CYTOSOLIC CALCIUM ION TRANSPORT |
7 |
53 |
1.901e-05 |
0.0001299 |
682 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
6 |
36 |
1.938e-05 |
0.0001313 |
683 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
6 |
36 |
1.938e-05 |
0.0001313 |
684 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
6 |
36 |
1.938e-05 |
0.0001313 |
685 |
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
6 |
36 |
1.938e-05 |
0.0001313 |
686 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
6 |
36 |
1.938e-05 |
0.0001313 |
687 |
T CELL SELECTION |
6 |
36 |
1.938e-05 |
0.0001313 |
688 |
REGULATION OF CELL SIZE |
12 |
172 |
1.951e-05 |
0.000132 |
689 |
CANONICAL WNT SIGNALING PATHWAY |
9 |
95 |
1.956e-05 |
0.0001321 |
690 |
SYNAPSE ORGANIZATION |
11 |
145 |
1.99e-05 |
0.000134 |
691 |
NEGATIVE REGULATION OF MAPK CASCADE |
11 |
145 |
1.99e-05 |
0.000134 |
692 |
REGULATION OF CELLULAR EXTRAVASATION |
5 |
22 |
2.014e-05 |
0.0001353 |
693 |
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
5 |
22 |
2.014e-05 |
0.0001353 |
694 |
REGULATION OF PROTEIN POLYMERIZATION |
12 |
173 |
2.068e-05 |
0.0001386 |
695 |
POSITIVE REGULATION OF PROTEOLYSIS |
18 |
363 |
2.084e-05 |
0.0001395 |
696 |
REGULATION OF DENDRITE DEVELOPMENT |
10 |
120 |
2.105e-05 |
0.0001407 |
697 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
8 |
74 |
2.167e-05 |
0.0001446 |
698 |
REGULATION OF MUSCLE CONTRACTION |
11 |
147 |
2.262e-05 |
0.0001507 |
699 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
10 |
121 |
2.263e-05 |
0.0001507 |
700 |
AXON EXTENSION |
6 |
37 |
2.283e-05 |
0.0001517 |
701 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
9 |
97 |
2.314e-05 |
0.0001536 |
702 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
8 |
75 |
2.392e-05 |
0.0001586 |
703 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
11 |
148 |
2.409e-05 |
0.0001595 |
704 |
REGULATION OF KIDNEY DEVELOPMENT |
7 |
55 |
2.436e-05 |
0.000161 |
705 |
PROSTATE GLAND MORPHOGENESIS |
5 |
23 |
2.541e-05 |
0.000167 |
706 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
5 |
23 |
2.541e-05 |
0.000167 |
707 |
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
5 |
23 |
2.541e-05 |
0.000167 |
708 |
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS |
5 |
23 |
2.541e-05 |
0.000167 |
709 |
GLIAL CELL DEVELOPMENT |
8 |
76 |
2.638e-05 |
0.0001731 |
710 |
COLLAGEN FIBRIL ORGANIZATION |
6 |
38 |
2.675e-05 |
0.0001751 |
711 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
6 |
38 |
2.675e-05 |
0.0001751 |
712 |
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE |
4 |
12 |
2.739e-05 |
0.0001782 |
713 |
CARTILAGE MORPHOGENESIS |
4 |
12 |
2.739e-05 |
0.0001782 |
714 |
AXON EXTENSION INVOLVED IN AXON GUIDANCE |
4 |
12 |
2.739e-05 |
0.0001782 |
715 |
HEMATOPOIETIC STEM CELL DIFFERENTIATION |
4 |
12 |
2.739e-05 |
0.0001782 |
716 |
DIENCEPHALON DEVELOPMENT |
8 |
77 |
2.903e-05 |
0.0001887 |
717 |
LIMBIC SYSTEM DEVELOPMENT |
9 |
100 |
2.956e-05 |
0.0001918 |
718 |
ENDOTHELIAL CELL MIGRATION |
7 |
57 |
3.09e-05 |
0.0001997 |
719 |
MYOTUBE DIFFERENTIATION |
7 |
57 |
3.09e-05 |
0.0001997 |
720 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
11 |
152 |
3.087e-05 |
0.0001997 |
721 |
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
6 |
39 |
3.12e-05 |
0.0002005 |
722 |
ANATOMICAL STRUCTURE MATURATION |
6 |
39 |
3.12e-05 |
0.0002005 |
723 |
CELLULAR RESPONSE TO NUTRIENT |
6 |
39 |
3.12e-05 |
0.0002005 |
724 |
PLATELET AGGREGATION |
6 |
39 |
3.12e-05 |
0.0002005 |
725 |
SPINAL CORD PATTERNING |
5 |
24 |
3.168e-05 |
0.000203 |
726 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
5 |
24 |
3.168e-05 |
0.000203 |
727 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
9 |
101 |
3.2e-05 |
0.0002048 |
728 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
11 |
153 |
3.28e-05 |
0.0002096 |
729 |
NEGATIVE REGULATION OF ION TRANSPORT |
10 |
127 |
3.442e-05 |
0.0002197 |
730 |
CELL CYCLE ARREST |
11 |
154 |
3.483e-05 |
0.000222 |
731 |
BONE MORPHOGENESIS |
8 |
79 |
3.503e-05 |
0.000223 |
732 |
MAMMARY GLAND MORPHOGENESIS |
6 |
40 |
3.622e-05 |
0.000229 |
733 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
6 |
40 |
3.622e-05 |
0.000229 |
734 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
12 |
183 |
3.605e-05 |
0.000229 |
735 |
DEVELOPMENTAL PIGMENTATION |
6 |
40 |
3.622e-05 |
0.000229 |
736 |
HINDBRAIN MORPHOGENESIS |
6 |
40 |
3.622e-05 |
0.000229 |
737 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
13 |
213 |
3.64e-05 |
0.0002298 |
738 |
REGULATION OF CELL PROJECTION ASSEMBLY |
11 |
155 |
3.698e-05 |
0.0002331 |
739 |
RESPONSE TO BACTERIUM |
22 |
528 |
3.792e-05 |
0.0002387 |
740 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
12 |
184 |
3.803e-05 |
0.0002391 |
741 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
8 |
80 |
3.839e-05 |
0.0002411 |
742 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
7 |
59 |
3.881e-05 |
0.000243 |
743 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
7 |
59 |
3.881e-05 |
0.000243 |
744 |
REGULATION OF VASCULOGENESIS |
4 |
13 |
3.906e-05 |
0.0002435 |
745 |
CELLULAR EXTRAVASATION |
5 |
25 |
3.909e-05 |
0.0002435 |
746 |
NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS |
4 |
13 |
3.906e-05 |
0.0002435 |
747 |
REGULATION OF CELL FATE SPECIFICATION |
4 |
13 |
3.906e-05 |
0.0002435 |
748 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
11 |
156 |
3.923e-05 |
0.000244 |
749 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
15 |
279 |
4.077e-05 |
0.0002533 |
750 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
6 |
41 |
4.187e-05 |
0.0002598 |
751 |
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS |
8 |
81 |
4.202e-05 |
0.0002604 |
752 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
13 |
216 |
4.208e-05 |
0.0002604 |
753 |
RESPONSE TO PURINE CONTAINING COMPOUND |
11 |
158 |
4.41e-05 |
0.0002725 |
754 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
10 |
131 |
4.491e-05 |
0.0002772 |
755 |
RECEPTOR METABOLIC PROCESS |
8 |
82 |
4.594e-05 |
0.0002831 |
756 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
12 |
188 |
4.692e-05 |
0.0002888 |
757 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
14 |
250 |
4.731e-05 |
0.0002908 |
758 |
REGULATION OF MESONEPHROS DEVELOPMENT |
5 |
26 |
4.778e-05 |
0.0002929 |
759 |
CELLULAR RESPONSE TO VITAMIN |
5 |
26 |
4.778e-05 |
0.0002929 |
760 |
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL |
6 |
42 |
4.82e-05 |
0.0002932 |
761 |
POSITIVE REGULATION OF DNA BINDING |
6 |
42 |
4.82e-05 |
0.0002932 |
762 |
DENDRITE MORPHOGENESIS |
6 |
42 |
4.82e-05 |
0.0002932 |
763 |
MAINTENANCE OF CELL NUMBER |
10 |
132 |
4.792e-05 |
0.0002932 |
764 |
EPITHELIAL CELL MORPHOGENESIS |
6 |
42 |
4.82e-05 |
0.0002932 |
765 |
CALCIUM ION IMPORT INTO CYTOSOL |
6 |
42 |
4.82e-05 |
0.0002932 |
766 |
REGULATION OF T CELL DIFFERENTIATION |
9 |
107 |
5.059e-05 |
0.0003073 |
767 |
REGULATION OF PROTEIN STABILITY |
13 |
221 |
5.327e-05 |
0.0003231 |
768 |
SOMITOGENESIS |
7 |
62 |
5.372e-05 |
0.0003251 |
769 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
7 |
62 |
5.372e-05 |
0.0003251 |
770 |
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
4 |
14 |
5.401e-05 |
0.0003251 |
771 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
4 |
14 |
5.401e-05 |
0.0003251 |
772 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
4 |
14 |
5.401e-05 |
0.0003251 |
773 |
ANGIOGENESIS INVOLVED IN WOUND HEALING |
4 |
14 |
5.401e-05 |
0.0003251 |
774 |
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
6 |
43 |
5.528e-05 |
0.0003319 |
775 |
CEREBRAL CORTEX CELL MIGRATION |
6 |
43 |
5.528e-05 |
0.0003319 |
776 |
REGULATION OF ASTROCYTE DIFFERENTIATION |
5 |
27 |
5.788e-05 |
0.0003466 |
777 |
MOTOR NEURON AXON GUIDANCE |
5 |
27 |
5.788e-05 |
0.0003466 |
778 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
10 |
135 |
5.802e-05 |
0.000347 |
779 |
CARDIAC SEPTUM DEVELOPMENT |
8 |
85 |
5.954e-05 |
0.0003556 |
780 |
DEFENSE RESPONSE |
38 |
1231 |
6.076e-05 |
0.0003624 |
781 |
EYE MORPHOGENESIS |
10 |
136 |
6.176e-05 |
0.0003679 |
782 |
BODY MORPHOGENESIS |
6 |
44 |
6.317e-05 |
0.0003759 |
783 |
PIGMENTATION |
8 |
86 |
6.476e-05 |
0.0003843 |
784 |
REGULATION OF HEART RATE |
8 |
86 |
6.476e-05 |
0.0003843 |
785 |
NEGATIVE REGULATION OF CELL CYCLE |
19 |
433 |
6.515e-05 |
0.0003862 |
786 |
ENDOCYTOSIS |
21 |
509 |
6.551e-05 |
0.0003878 |
787 |
ACTIVATION OF MAPK ACTIVITY |
10 |
137 |
6.571e-05 |
0.0003885 |
788 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
14 |
258 |
6.646e-05 |
0.0003924 |
789 |
REGULATION OF MUSCLE SYSTEM PROCESS |
12 |
195 |
6.684e-05 |
0.0003942 |
790 |
REGULATION OF FIBROBLAST MIGRATION |
5 |
28 |
6.956e-05 |
0.0004076 |
791 |
PLACENTA BLOOD VESSEL DEVELOPMENT |
5 |
28 |
6.956e-05 |
0.0004076 |
792 |
REGULATION OF SPROUTING ANGIOGENESIS |
5 |
28 |
6.956e-05 |
0.0004076 |
793 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
5 |
28 |
6.956e-05 |
0.0004076 |
794 |
METANEPHROS MORPHOGENESIS |
5 |
28 |
6.956e-05 |
0.0004076 |
795 |
MAINTENANCE OF LOCATION |
10 |
138 |
6.986e-05 |
0.0004089 |
796 |
THYMOCYTE AGGREGATION |
6 |
45 |
7.193e-05 |
0.0004189 |
797 |
T CELL DIFFERENTIATION IN THYMUS |
6 |
45 |
7.193e-05 |
0.0004189 |
798 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
6 |
45 |
7.193e-05 |
0.0004189 |
799 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
17 |
363 |
7.173e-05 |
0.0004189 |
800 |
OLFACTORY BULB INTERNEURON DIFFERENTIATION |
4 |
15 |
7.274e-05 |
0.0004215 |
801 |
MESENCHYMAL TO EPITHELIAL TRANSITION |
4 |
15 |
7.274e-05 |
0.0004215 |
802 |
ENDOCARDIAL CUSHION FORMATION |
4 |
15 |
7.274e-05 |
0.0004215 |
803 |
NEPHRIC DUCT DEVELOPMENT |
4 |
15 |
7.274e-05 |
0.0004215 |
804 |
CELLULAR RESPONSE TO RETINOIC ACID |
7 |
65 |
7.304e-05 |
0.0004222 |
805 |
CALCIUM ION IMPORT |
7 |
65 |
7.304e-05 |
0.0004222 |
806 |
RESPONSE TO ORGANOPHOSPHORUS |
10 |
139 |
7.424e-05 |
0.0004286 |
807 |
MYELOID CELL HOMEOSTASIS |
8 |
88 |
7.633e-05 |
0.0004396 |
808 |
LEUKOCYTE PROLIFERATION |
8 |
88 |
7.633e-05 |
0.0004396 |
809 |
REGULATION OF PROTEIN BINDING |
11 |
168 |
7.699e-05 |
0.0004423 |
810 |
RESPONSE TO CARBOHYDRATE |
11 |
168 |
7.699e-05 |
0.0004423 |
811 |
CELLULAR COMPONENT DISASSEMBLY |
21 |
515 |
7.731e-05 |
0.0004436 |
812 |
REGULATION OF STEM CELL DIFFERENTIATION |
9 |
113 |
7.756e-05 |
0.0004445 |
813 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
7 |
66 |
8.061e-05 |
0.0004602 |
814 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
7 |
66 |
8.061e-05 |
0.0004602 |
815 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
7 |
66 |
8.061e-05 |
0.0004602 |
816 |
REGULATION OF HORMONE LEVELS |
20 |
478 |
8.074e-05 |
0.0004604 |
817 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
14 |
263 |
8.16e-05 |
0.0004643 |
818 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
6 |
46 |
8.163e-05 |
0.0004643 |
819 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
5 |
29 |
8.297e-05 |
0.0004702 |
820 |
REGULATION OF HEART MORPHOGENESIS |
5 |
29 |
8.297e-05 |
0.0004702 |
821 |
PIGMENT CELL DIFFERENTIATION |
5 |
29 |
8.297e-05 |
0.0004702 |
822 |
NOTCH SIGNALING PATHWAY |
9 |
114 |
8.306e-05 |
0.0004702 |
823 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
10 |
141 |
8.371e-05 |
0.0004733 |
824 |
NEGATIVE REGULATION OF SECRETION |
12 |
200 |
8.519e-05 |
0.0004811 |
825 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
8 |
90 |
8.958e-05 |
0.0005052 |
826 |
MUSCLE FIBER DEVELOPMENT |
6 |
47 |
9.234e-05 |
0.0005202 |
827 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
10 |
143 |
9.418e-05 |
0.0005299 |
828 |
DENDRITIC CELL CHEMOTAXIS |
4 |
16 |
9.578e-05 |
0.000535 |
829 |
REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
4 |
16 |
9.578e-05 |
0.000535 |
830 |
NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT |
4 |
16 |
9.578e-05 |
0.000535 |
831 |
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
4 |
16 |
9.578e-05 |
0.000535 |
832 |
ATRIOVENTRICULAR VALVE MORPHOGENESIS |
4 |
16 |
9.578e-05 |
0.000535 |
833 |
NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION |
4 |
16 |
9.578e-05 |
0.000535 |
834 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
22 |
563 |
9.721e-05 |
0.0005423 |
835 |
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS |
7 |
68 |
9.768e-05 |
0.0005437 |
836 |
NERVE DEVELOPMENT |
7 |
68 |
9.768e-05 |
0.0005437 |
837 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
5 |
30 |
9.828e-05 |
0.0005463 |
838 |
DIVALENT INORGANIC CATION TRANSPORT |
14 |
268 |
9.966e-05 |
0.0005534 |
839 |
LEUKOCYTE CHEMOTAXIS |
9 |
117 |
0.0001016 |
0.0005632 |
840 |
REGULATION OF MYOBLAST DIFFERENTIATION |
6 |
48 |
0.0001041 |
0.0005755 |
841 |
POSITIVE REGULATION OF WOUND HEALING |
6 |
48 |
0.0001041 |
0.0005755 |
842 |
REGULATION OF INTERLEUKIN 2 PRODUCTION |
6 |
48 |
0.0001041 |
0.0005755 |
843 |
ACTIN FILAMENT ORGANIZATION |
11 |
174 |
0.0001054 |
0.0005819 |
844 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
9 |
118 |
0.0001084 |
0.0005979 |
845 |
REGULATION OF LEUKOCYTE PROLIFERATION |
12 |
206 |
0.0001128 |
0.0006212 |
846 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
8 |
93 |
0.000113 |
0.0006214 |
847 |
ADULT WALKING BEHAVIOR |
5 |
31 |
0.0001157 |
0.000634 |
848 |
CARDIAC ATRIUM DEVELOPMENT |
5 |
31 |
0.0001157 |
0.000634 |
849 |
WALKING BEHAVIOR |
5 |
31 |
0.0001157 |
0.000634 |
850 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
6 |
49 |
0.0001171 |
0.0006404 |
851 |
LYMPHOCYTE MIGRATION |
6 |
49 |
0.0001171 |
0.0006404 |
852 |
MUSCLE ORGAN MORPHOGENESIS |
7 |
70 |
0.0001176 |
0.0006422 |
853 |
BRANCH ELONGATION OF AN EPITHELIUM |
4 |
17 |
0.0001237 |
0.0006716 |
854 |
CYTOKINE PRODUCTION |
9 |
120 |
0.0001234 |
0.0006716 |
855 |
NEGATIVE REGULATION OF ANOIKIS |
4 |
17 |
0.0001237 |
0.0006716 |
856 |
MYELIN ASSEMBLY |
4 |
17 |
0.0001237 |
0.0006716 |
857 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
4 |
17 |
0.0001237 |
0.0006716 |
858 |
CELL RECOGNITION |
10 |
148 |
0.0001253 |
0.0006795 |
859 |
CELLULAR RESPONSE TO PEPTIDE |
14 |
274 |
0.0001258 |
0.0006816 |
860 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
12 |
209 |
0.0001293 |
0.0006995 |
861 |
FACE DEVELOPMENT |
6 |
50 |
0.0001313 |
0.0007098 |
862 |
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS |
5 |
32 |
0.0001353 |
0.0007297 |
863 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
5 |
32 |
0.0001353 |
0.0007297 |
864 |
MYELOID LEUKOCYTE DIFFERENTIATION |
8 |
96 |
0.0001412 |
0.0007605 |
865 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
12 |
211 |
0.0001414 |
0.0007605 |
866 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
6 |
51 |
0.0001469 |
0.0007865 |
867 |
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT |
6 |
51 |
0.0001469 |
0.0007865 |
868 |
HOMOTYPIC CELL CELL ADHESION |
6 |
51 |
0.0001469 |
0.0007865 |
869 |
REGULATION OF CHROMOSOME ORGANIZATION |
14 |
278 |
0.0001464 |
0.0007865 |
870 |
ENDOCRINE SYSTEM DEVELOPMENT |
9 |
123 |
0.000149 |
0.000797 |
871 |
ERYTHROCYTE HOMEOSTASIS |
7 |
73 |
0.0001535 |
0.00082 |
872 |
NEUROLOGICAL SYSTEM PROCESS |
37 |
1242 |
0.0001568 |
0.0008352 |
873 |
RETINAL GANGLION CELL AXON GUIDANCE |
4 |
18 |
0.0001571 |
0.0008352 |
874 |
ATRIAL SEPTUM DEVELOPMENT |
4 |
18 |
0.0001571 |
0.0008352 |
875 |
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS |
13 |
246 |
0.0001568 |
0.0008352 |
876 |
DENDRITIC CELL DIFFERENTIATION |
5 |
33 |
0.0001575 |
0.0008363 |
877 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
8 |
98 |
0.0001631 |
0.0008653 |
878 |
TISSUE REGENERATION |
6 |
52 |
0.0001639 |
0.0008685 |
879 |
REGULATION OF DENDRITE MORPHOGENESIS |
7 |
74 |
0.0001673 |
0.0008845 |
880 |
ACTIN MEDIATED CELL CONTRACTION |
7 |
74 |
0.0001673 |
0.0008845 |
881 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
12 |
216 |
0.0001759 |
0.0009292 |
882 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
9 |
126 |
0.0001789 |
0.000944 |
883 |
NEURON PROJECTION EXTENSION |
6 |
53 |
0.0001824 |
0.0009566 |
884 |
ORGAN FORMATION |
5 |
34 |
0.0001822 |
0.0009566 |
885 |
PROTEIN KINASE B SIGNALING |
5 |
34 |
0.0001822 |
0.0009566 |
886 |
CELLULAR GLUCOSE HOMEOSTASIS |
7 |
75 |
0.000182 |
0.0009566 |
887 |
SKELETAL MUSCLE CELL DIFFERENTIATION |
6 |
53 |
0.0001824 |
0.0009566 |
888 |
RESPONSE TO CYTOKINE |
25 |
714 |
0.0001846 |
0.0009672 |
889 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
8 |
100 |
0.0001877 |
0.0009824 |
890 |
REGULATION OF ACTIN FILAMENT LENGTH |
10 |
156 |
0.000193 |
0.001009 |
891 |
THYMIC T CELL SELECTION |
4 |
19 |
0.0001965 |
0.00102 |
892 |
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
19 |
0.0001965 |
0.00102 |
893 |
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
4 |
19 |
0.0001965 |
0.00102 |
894 |
PLATELET MORPHOGENESIS |
4 |
19 |
0.0001965 |
0.00102 |
895 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
4 |
19 |
0.0001965 |
0.00102 |
896 |
ATRIOVENTRICULAR VALVE DEVELOPMENT |
4 |
19 |
0.0001965 |
0.00102 |
897 |
REGULATION OF EXTENT OF CELL GROWTH |
8 |
101 |
0.0002011 |
0.001042 |
898 |
CAMERA TYPE EYE MORPHOGENESIS |
8 |
101 |
0.0002011 |
0.001042 |
899 |
VENTRICULAR SEPTUM DEVELOPMENT |
6 |
54 |
0.0002025 |
0.001048 |
900 |
NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
5 |
35 |
0.0002099 |
0.001084 |
901 |
BONE REMODELING |
5 |
35 |
0.0002099 |
0.001084 |
902 |
CALCIUM ION TRANSMEMBRANE TRANSPORT |
10 |
159 |
0.0002253 |
0.001162 |
903 |
LYMPHOCYTE COSTIMULATION |
7 |
78 |
0.0002327 |
0.001199 |
904 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
9 |
131 |
0.0002399 |
0.001234 |
905 |
OLFACTORY LOBE DEVELOPMENT |
5 |
36 |
0.0002406 |
0.001234 |
906 |
POSITIVE CHEMOTAXIS |
5 |
36 |
0.0002406 |
0.001234 |
907 |
HEAD MORPHOGENESIS |
5 |
36 |
0.0002406 |
0.001234 |
908 |
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
4 |
20 |
0.0002426 |
0.001239 |
909 |
MELANOCYTE DIFFERENTIATION |
4 |
20 |
0.0002426 |
0.001239 |
910 |
NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
4 |
20 |
0.0002426 |
0.001239 |
911 |
REGULATION OF MONOCYTE CHEMOTAXIS |
4 |
20 |
0.0002426 |
0.001239 |
912 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
16 |
365 |
0.0002472 |
0.001261 |
913 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
6 |
56 |
0.0002479 |
0.001263 |
914 |
PROTEIN AUTOPHOSPHORYLATION |
11 |
192 |
0.00025 |
0.001272 |
915 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
7 |
79 |
0.0002519 |
0.00128 |
916 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
7 |
79 |
0.0002519 |
0.00128 |
917 |
NEGATIVE REGULATION OF PROTEOLYSIS |
15 |
329 |
0.0002532 |
0.001285 |
918 |
POSITIVE REGULATION OF CELL DIVISION |
9 |
132 |
0.0002539 |
0.001287 |
919 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
11 |
193 |
0.0002614 |
0.001324 |
920 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
6 |
57 |
0.0002734 |
0.001383 |
921 |
CORONARY VASCULATURE DEVELOPMENT |
5 |
37 |
0.0002746 |
0.001384 |
922 |
MYOBLAST DIFFERENTIATION |
5 |
37 |
0.0002746 |
0.001384 |
923 |
GLIAL CELL MIGRATION |
5 |
37 |
0.0002746 |
0.001384 |
924 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
9 |
134 |
0.0002841 |
0.00143 |
925 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
16 |
370 |
0.0002877 |
0.001447 |
926 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
14 |
297 |
0.000289 |
0.001452 |
927 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
12 |
228 |
0.0002895 |
0.001453 |
928 |
PHENOL CONTAINING COMPOUND METABOLIC PROCESS |
7 |
81 |
0.0002942 |
0.001475 |
929 |
DENDRITIC CELL MIGRATION |
4 |
21 |
0.0002959 |
0.001477 |
930 |
REGULATION OF RUFFLE ASSEMBLY |
4 |
21 |
0.0002959 |
0.001477 |
931 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
4 |
21 |
0.0002959 |
0.001477 |
932 |
RUFFLE ORGANIZATION |
4 |
21 |
0.0002959 |
0.001477 |
933 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
6 |
58 |
0.000301 |
0.001501 |
934 |
POSITIVE REGULATION OF ORGAN GROWTH |
5 |
38 |
0.0003122 |
0.001555 |
935 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
9 |
136 |
0.0003171 |
0.001578 |
936 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
8 |
108 |
0.0003185 |
0.001583 |
937 |
PROTEIN MATURATION |
13 |
265 |
0.0003235 |
0.001606 |
938 |
REGULATION OF TRANSPORTER ACTIVITY |
11 |
198 |
0.0003255 |
0.001615 |
939 |
RECEPTOR MEDIATED ENDOCYTOSIS |
12 |
231 |
0.000326 |
0.001616 |
940 |
RESPONSE TO ALKALOID |
9 |
137 |
0.0003348 |
0.001657 |
941 |
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
5 |
39 |
0.0003535 |
0.001746 |
942 |
ASTROCYTE DIFFERENTIATION |
5 |
39 |
0.0003535 |
0.001746 |
943 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
11 |
200 |
0.0003546 |
0.00175 |
944 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
4 |
22 |
0.0003572 |
0.001751 |
945 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
4 |
22 |
0.0003572 |
0.001751 |
946 |
POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION |
4 |
22 |
0.0003572 |
0.001751 |
947 |
PROTEIN LOCALIZATION TO CELL SURFACE |
4 |
22 |
0.0003572 |
0.001751 |
948 |
REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
4 |
22 |
0.0003572 |
0.001751 |
949 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
4 |
22 |
0.0003572 |
0.001751 |
950 |
REGULATION OF MONOOXYGENASE ACTIVITY |
6 |
60 |
0.0003626 |
0.001772 |
951 |
OLIGODENDROCYTE DIFFERENTIATION |
6 |
60 |
0.0003626 |
0.001772 |
952 |
LEUKOCYTE HOMEOSTASIS |
6 |
60 |
0.0003626 |
0.001772 |
953 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
7 |
84 |
0.0003681 |
0.001794 |
954 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
7 |
84 |
0.0003681 |
0.001794 |
955 |
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
84 |
0.0003681 |
0.001794 |
956 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
8 |
111 |
0.0003835 |
0.001867 |
957 |
GLUCOSE HOMEOSTASIS |
10 |
170 |
0.0003851 |
0.001871 |
958 |
CARBOHYDRATE HOMEOSTASIS |
10 |
170 |
0.0003851 |
0.001871 |
959 |
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
7 |
85 |
0.0003958 |
0.00192 |
960 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
6 |
61 |
0.0003969 |
0.001924 |
961 |
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
5 |
40 |
0.0003988 |
0.001929 |
962 |
ENDODERMAL CELL DIFFERENTIATION |
5 |
40 |
0.0003988 |
0.001929 |
963 |
TISSUE HOMEOSTASIS |
10 |
171 |
0.0004035 |
0.001949 |
964 |
RESPONSE TO AMINO ACID |
8 |
112 |
0.0004074 |
0.001967 |
965 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
7 |
86 |
0.0004251 |
0.00205 |
966 |
RESPONSE TO MAGNESIUM ION |
4 |
23 |
0.0004271 |
0.002051 |
967 |
REGULATION OF OSTEOBLAST PROLIFERATION |
4 |
23 |
0.0004271 |
0.002051 |
968 |
STRIATED MUSCLE ADAPTATION |
4 |
23 |
0.0004271 |
0.002051 |
969 |
NEUROTROPHIN SIGNALING PATHWAY |
4 |
23 |
0.0004271 |
0.002051 |
970 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
8 |
113 |
0.0004326 |
0.002075 |
971 |
REGULATION OF TISSUE REMODELING |
6 |
62 |
0.0004336 |
0.002078 |
972 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
28 |
891 |
0.0004464 |
0.002137 |
973 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
5 |
41 |
0.0004484 |
0.002138 |
974 |
REGULATION OF MEMBRANE DEPOLARIZATION |
5 |
41 |
0.0004484 |
0.002138 |
975 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
5 |
41 |
0.0004484 |
0.002138 |
976 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
5 |
41 |
0.0004484 |
0.002138 |
977 |
REGULATION OF EMBRYONIC DEVELOPMENT |
8 |
114 |
0.000459 |
0.002186 |
978 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
6 |
63 |
0.000473 |
0.00225 |
979 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
9 |
144 |
0.0004827 |
0.002294 |
980 |
RESPONSE TO INTERLEUKIN 1 |
8 |
115 |
0.0004866 |
0.00231 |
981 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
7 |
88 |
0.000489 |
0.002319 |
982 |
REGULATION OF HISTONE DEACETYLATION |
4 |
24 |
0.0005061 |
0.002374 |
983 |
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
5 |
42 |
0.0005025 |
0.002374 |
984 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
4 |
24 |
0.0005061 |
0.002374 |
985 |
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
4 |
24 |
0.0005061 |
0.002374 |
986 |
AXON REGENERATION |
4 |
24 |
0.0005061 |
0.002374 |
987 |
DETECTION OF MECHANICAL STIMULUS |
5 |
42 |
0.0005025 |
0.002374 |
988 |
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
4 |
24 |
0.0005061 |
0.002374 |
989 |
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
5 |
42 |
0.0005025 |
0.002374 |
990 |
REGULATION OF ODONTOGENESIS |
4 |
24 |
0.0005061 |
0.002374 |
991 |
REGULATION OF ANOIKIS |
4 |
24 |
0.0005061 |
0.002374 |
992 |
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
4 |
24 |
0.0005061 |
0.002374 |
993 |
RESPONSE TO IONIZING RADIATION |
9 |
145 |
0.0005076 |
0.002379 |
994 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
6 |
64 |
0.0005151 |
0.002408 |
995 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
15 |
352 |
0.0005155 |
0.002408 |
996 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
6 |
64 |
0.0005151 |
0.002408 |
997 |
RESPONSE TO HEAT |
7 |
89 |
0.0005237 |
0.002442 |
998 |
B CELL DIFFERENTIATION |
7 |
89 |
0.0005237 |
0.002442 |
999 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
9 |
146 |
0.0005336 |
0.002485 |
1000 |
LIPID MODIFICATION |
11 |
210 |
0.0005352 |
0.00249 |
1001 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
11 |
211 |
0.0005568 |
0.002588 |
1002 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
5 |
43 |
0.0005613 |
0.002607 |
1003 |
GLYCEROLIPID METABOLIC PROCESS |
15 |
356 |
0.0005793 |
0.002688 |
1004 |
BONE TRABECULA MORPHOGENESIS |
3 |
11 |
0.0005868 |
0.002701 |
1005 |
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
3 |
11 |
0.0005868 |
0.002701 |
1006 |
POSITIVE REGULATION OF FIBROBLAST MIGRATION |
3 |
11 |
0.0005868 |
0.002701 |
1007 |
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
3 |
11 |
0.0005868 |
0.002701 |
1008 |
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION |
3 |
11 |
0.0005868 |
0.002701 |
1009 |
LYMPHOID PROGENITOR CELL DIFFERENTIATION |
3 |
11 |
0.0005868 |
0.002701 |
1010 |
IMMUNOLOGICAL SYNAPSE FORMATION |
3 |
11 |
0.0005868 |
0.002701 |
1011 |
CORPUS CALLOSUM DEVELOPMENT |
3 |
11 |
0.0005868 |
0.002701 |
1012 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
16 |
395 |
0.0005877 |
0.002702 |
1013 |
POSITIVE REGULATION OF COAGULATION |
4 |
25 |
0.0005951 |
0.002733 |
1014 |
DORSAL VENTRAL PATTERN FORMATION |
7 |
91 |
0.0005989 |
0.002748 |
1015 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
6 |
66 |
0.000608 |
0.002782 |
1016 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
6 |
66 |
0.000608 |
0.002782 |
1017 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
6 |
66 |
0.000608 |
0.002782 |
1018 |
POSITIVE REGULATION OF NEURON DEATH |
6 |
67 |
0.000659 |
0.003003 |
1019 |
CELL AGING |
6 |
67 |
0.000659 |
0.003003 |
1020 |
CELLULAR RESPONSE TO DRUG |
6 |
67 |
0.000659 |
0.003003 |
1021 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
6 |
67 |
0.000659 |
0.003003 |
1022 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
9 |
151 |
0.0006805 |
0.003098 |
1023 |
ACTIN FILAMENT BASED MOVEMENT |
7 |
93 |
0.0006825 |
0.003101 |
1024 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
7 |
93 |
0.0006825 |
0.003101 |
1025 |
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
4 |
26 |
0.0006946 |
0.003138 |
1026 |
LUNG MORPHOGENESIS |
5 |
45 |
0.0006944 |
0.003138 |
1027 |
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
4 |
26 |
0.0006946 |
0.003138 |
1028 |
MESODERMAL CELL DIFFERENTIATION |
4 |
26 |
0.0006946 |
0.003138 |
1029 |
SMOOTH MUSCLE CONTRACTION |
5 |
45 |
0.0006944 |
0.003138 |
1030 |
REGULATION OF CELL FATE COMMITMENT |
4 |
26 |
0.0006946 |
0.003138 |
1031 |
MEMBRANE DOCKING |
6 |
68 |
0.0007134 |
0.003213 |
1032 |
REGULATION OF PHAGOCYTOSIS |
6 |
68 |
0.0007134 |
0.003213 |
1033 |
AMINOGLYCAN CATABOLIC PROCESS |
6 |
68 |
0.0007134 |
0.003213 |
1034 |
PHOSPHOLIPID METABOLIC PROCESS |
15 |
364 |
0.0007273 |
0.003273 |
1035 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
8 |
123 |
0.0007602 |
0.003414 |
1036 |
MULTICELLULAR ORGANISMAL SIGNALING |
8 |
123 |
0.0007602 |
0.003414 |
1037 |
CARDIAC LEFT VENTRICLE MORPHOGENESIS |
3 |
12 |
0.0007732 |
0.003423 |
1038 |
ROUNDABOUT SIGNALING PATHWAY |
3 |
12 |
0.0007732 |
0.003423 |
1039 |
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH |
3 |
12 |
0.0007732 |
0.003423 |
1040 |
REGULATION OF ENDOTHELIAL CELL DEVELOPMENT |
3 |
12 |
0.0007732 |
0.003423 |
1041 |
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
6 |
69 |
0.0007711 |
0.003423 |
1042 |
POLARIZED EPITHELIAL CELL DIFFERENTIATION |
3 |
12 |
0.0007732 |
0.003423 |
1043 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
5 |
46 |
0.0007691 |
0.003423 |
1044 |
REGULATION OF MACROPHAGE CYTOKINE PRODUCTION |
3 |
12 |
0.0007732 |
0.003423 |
1045 |
NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY |
3 |
12 |
0.0007732 |
0.003423 |
1046 |
POSITIVE REGULATION OF PHAGOCYTOSIS |
5 |
46 |
0.0007691 |
0.003423 |
1047 |
POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
3 |
12 |
0.0007732 |
0.003423 |
1048 |
REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER |
3 |
12 |
0.0007732 |
0.003423 |
1049 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
6 |
69 |
0.0007711 |
0.003423 |
1050 |
RENAL FILTRATION |
3 |
12 |
0.0007732 |
0.003423 |
1051 |
NEGATIVE REGULATION OF HEART GROWTH |
3 |
12 |
0.0007732 |
0.003423 |
1052 |
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
7 |
95 |
0.000775 |
0.003428 |
1053 |
POSITIVE REGULATION OF HEART GROWTH |
4 |
27 |
0.0008053 |
0.003542 |
1054 |
CELL PROLIFERATION IN FOREBRAIN |
4 |
27 |
0.0008053 |
0.003542 |
1055 |
POSITIVE REGULATION OF FILOPODIUM ASSEMBLY |
4 |
27 |
0.0008053 |
0.003542 |
1056 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
4 |
27 |
0.0008053 |
0.003542 |
1057 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
4 |
27 |
0.0008053 |
0.003542 |
1058 |
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS |
4 |
27 |
0.0008053 |
0.003542 |
1059 |
SENSORY PERCEPTION OF MECHANICAL STIMULUS |
9 |
155 |
0.0008205 |
0.003605 |
1060 |
MAINTENANCE OF LOCATION IN CELL |
7 |
96 |
0.0008249 |
0.003621 |
1061 |
THYMUS DEVELOPMENT |
5 |
47 |
0.0008496 |
0.003723 |
1062 |
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
5 |
47 |
0.0008496 |
0.003723 |
1063 |
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
6 |
71 |
0.0008973 |
0.003928 |
1064 |
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE |
4 |
28 |
0.000928 |
0.004047 |
1065 |
REGULATION OF NEUROBLAST PROLIFERATION |
4 |
28 |
0.000928 |
0.004047 |
1066 |
MUSCLE HYPERTROPHY |
4 |
28 |
0.000928 |
0.004047 |
1067 |
MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
28 |
0.000928 |
0.004047 |
1068 |
MEMORY |
7 |
98 |
0.0009322 |
0.004061 |
1069 |
RESPONSE TO AXON INJURY |
5 |
48 |
0.0009363 |
0.004076 |
1070 |
NEGATIVE REGULATION OF CELL ACTIVATION |
9 |
158 |
0.0009401 |
0.004088 |
1071 |
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS |
3 |
13 |
0.0009935 |
0.004276 |
1072 |
SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL INTERNEURON MIGRATION |
3 |
13 |
0.0009935 |
0.004276 |
1073 |
VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION |
3 |
13 |
0.0009935 |
0.004276 |
1074 |
SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION |
3 |
13 |
0.0009935 |
0.004276 |
1075 |
HEMATOPOIETIC STEM CELL PROLIFERATION |
3 |
13 |
0.0009935 |
0.004276 |
1076 |
HEART VALVE FORMATION |
3 |
13 |
0.0009935 |
0.004276 |
1077 |
NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
3 |
13 |
0.0009935 |
0.004276 |
1078 |
RESPONSE TO PARATHYROID HORMONE |
3 |
13 |
0.0009935 |
0.004276 |
1079 |
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY |
3 |
13 |
0.0009935 |
0.004276 |
1080 |
EXTRACELLULAR FIBRIL ORGANIZATION |
3 |
13 |
0.0009935 |
0.004276 |
1081 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
3 |
13 |
0.0009935 |
0.004276 |
1082 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
12 |
263 |
0.001026 |
0.004414 |
1083 |
NEGATIVE REGULATION OF PEPTIDE SECRETION |
5 |
49 |
0.001029 |
0.004415 |
1084 |
REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY |
5 |
49 |
0.001029 |
0.004415 |
1085 |
CARDIAC SEPTUM MORPHOGENESIS |
5 |
49 |
0.001029 |
0.004415 |
1086 |
POSITIVE REGULATION OF PROTEIN BINDING |
6 |
73 |
0.001039 |
0.004447 |
1087 |
HIPPOCAMPUS DEVELOPMENT |
6 |
73 |
0.001039 |
0.004447 |
1088 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
7 |
100 |
0.00105 |
0.004491 |
1089 |
CELL PROJECTION ASSEMBLY |
12 |
264 |
0.00106 |
0.004518 |
1090 |
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
4 |
29 |
0.001063 |
0.004518 |
1091 |
REGULATION OF VACUOLAR TRANSPORT |
4 |
29 |
0.001063 |
0.004518 |
1092 |
STEM CELL DIVISION |
4 |
29 |
0.001063 |
0.004518 |
1093 |
RESPONSE TO ISCHEMIA |
4 |
29 |
0.001063 |
0.004518 |
1094 |
MUSCLE ADAPTATION |
4 |
29 |
0.001063 |
0.004518 |
1095 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
4 |
29 |
0.001063 |
0.004518 |
1096 |
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS |
6 |
74 |
0.001116 |
0.004737 |
1097 |
LYMPHOCYTE HOMEOSTASIS |
5 |
50 |
0.001129 |
0.004781 |
1098 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
5 |
50 |
0.001129 |
0.004781 |
1099 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
5 |
50 |
0.001129 |
0.004781 |
1100 |
LEARNING |
8 |
131 |
0.001146 |
0.004843 |
1101 |
NEGATIVE REGULATION OF BINDING |
8 |
131 |
0.001146 |
0.004843 |
1102 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
7 |
102 |
0.00118 |
0.004981 |
1103 |
GRANULOCYTE MIGRATION |
6 |
75 |
0.001197 |
0.005049 |
1104 |
B CELL ACTIVATION |
8 |
132 |
0.001203 |
0.005072 |
1105 |
ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY |
4 |
30 |
0.001212 |
0.005088 |
1106 |
CEREBELLAR CORTEX MORPHOGENESIS |
4 |
30 |
0.001212 |
0.005088 |
1107 |
MYOTUBE CELL DEVELOPMENT |
4 |
30 |
0.001212 |
0.005088 |
1108 |
REGULATION OF VASCULAR PERMEABILITY |
4 |
30 |
0.001212 |
0.005088 |
1109 |
HORMONE METABOLIC PROCESS |
9 |
164 |
0.001222 |
0.005127 |
1110 |
REGULATION OF NEUROTRANSMITTER SECRETION |
5 |
51 |
0.001236 |
0.005172 |
1111 |
NEURAL CREST CELL MIGRATION |
5 |
51 |
0.001236 |
0.005172 |
1112 |
REGULATION OF INTERLEUKIN 12 PRODUCTION |
5 |
51 |
0.001236 |
0.005172 |
1113 |
STRESS FIBER ASSEMBLY |
3 |
14 |
0.00125 |
0.005183 |
1114 |
CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY |
3 |
14 |
0.00125 |
0.005183 |
1115 |
POSITIVE REGULATION OF VACUOLAR TRANSPORT |
3 |
14 |
0.00125 |
0.005183 |
1116 |
POSITIVE REGULATION OF HISTONE DEACETYLATION |
3 |
14 |
0.00125 |
0.005183 |
1117 |
EPITHELIAL CELL CELL ADHESION |
3 |
14 |
0.00125 |
0.005183 |
1118 |
ATRIAL SEPTUM MORPHOGENESIS |
3 |
14 |
0.00125 |
0.005183 |
1119 |
CONVERGENT EXTENSION |
3 |
14 |
0.00125 |
0.005183 |
1120 |
CATECHOLAMINE TRANSPORT |
3 |
14 |
0.00125 |
0.005183 |
1121 |
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY |
3 |
14 |
0.00125 |
0.005183 |
1122 |
RESPONSE TO LAMINAR FLUID SHEAR STRESS |
3 |
14 |
0.00125 |
0.005183 |
1123 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
6 |
76 |
0.001283 |
0.005314 |
1124 |
AMINOGLYCAN METABOLIC PROCESS |
9 |
166 |
0.00133 |
0.005504 |
1125 |
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE |
5 |
52 |
0.00135 |
0.005584 |
1126 |
REGULATION OF CELL DIVISION |
12 |
272 |
0.001368 |
0.005653 |
1127 |
REGULATION OF MICROTUBULE POLYMERIZATION |
4 |
31 |
0.001374 |
0.005663 |
1128 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
4 |
31 |
0.001374 |
0.005663 |
1129 |
REGULATION OF PLATELET ACTIVATION |
4 |
31 |
0.001374 |
0.005663 |
1130 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
8 |
135 |
0.00139 |
0.005724 |
1131 |
REGULATION OF MULTI ORGANISM PROCESS |
17 |
470 |
0.001392 |
0.005728 |
1132 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
5 |
53 |
0.001472 |
0.006038 |
1133 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
5 |
53 |
0.001472 |
0.006038 |
1134 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
53 |
0.001472 |
0.006038 |
1135 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
14 |
351 |
0.001475 |
0.006046 |
1136 |
PLASMA MEMBRANE ORGANIZATION |
10 |
203 |
0.001507 |
0.006167 |
1137 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
10 |
203 |
0.001507 |
0.006167 |
1138 |
NEGATIVE REGULATION OF HISTONE ACETYLATION |
3 |
15 |
0.001544 |
0.00628 |
1139 |
REGULATION OF MESODERM DEVELOPMENT |
3 |
15 |
0.001544 |
0.00628 |
1140 |
GRANULOCYTE DIFFERENTIATION |
3 |
15 |
0.001544 |
0.00628 |
1141 |
REGULATION OF NEUROTRANSMITTER UPTAKE |
3 |
15 |
0.001544 |
0.00628 |
1142 |
CHRONIC INFLAMMATORY RESPONSE |
3 |
15 |
0.001544 |
0.00628 |
1143 |
VENOUS BLOOD VESSEL DEVELOPMENT |
3 |
15 |
0.001544 |
0.00628 |
1144 |
MRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
3 |
15 |
0.001544 |
0.00628 |
1145 |
POSITIVE REGULATION OF BMP SIGNALING PATHWAY |
4 |
32 |
0.001551 |
0.006292 |
1146 |
REGULATION OF ACTIN CYTOSKELETON REORGANIZATION |
4 |
32 |
0.001551 |
0.006292 |
1147 |
PEPTIDE HORMONE PROCESSING |
4 |
32 |
0.001551 |
0.006292 |
1148 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
7 |
107 |
0.001558 |
0.006315 |
1149 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
6 |
79 |
0.001568 |
0.006349 |
1150 |
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS |
5 |
54 |
0.001601 |
0.006467 |
1151 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
5 |
54 |
0.001601 |
0.006467 |
1152 |
PLACENTA DEVELOPMENT |
8 |
138 |
0.001599 |
0.006467 |
1153 |
RESPONSE TO INSULIN |
10 |
205 |
0.001621 |
0.00654 |
1154 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
9 |
172 |
0.0017 |
0.006854 |
1155 |
NEURON RECOGNITION |
4 |
33 |
0.001743 |
0.006974 |
1156 |
PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS |
4 |
33 |
0.001743 |
0.006974 |
1157 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
5 |
55 |
0.001739 |
0.006974 |
1158 |
POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION |
4 |
33 |
0.001743 |
0.006974 |
1159 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
4 |
33 |
0.001743 |
0.006974 |
1160 |
NEURON PROJECTION REGENERATION |
4 |
33 |
0.001743 |
0.006974 |
1161 |
NEGATIVE REGULATION OF JNK CASCADE |
4 |
33 |
0.001743 |
0.006974 |
1162 |
RESPONSE TO DEXAMETHASONE |
4 |
33 |
0.001743 |
0.006974 |
1163 |
RESPONSE TO HYDROGEN PEROXIDE |
7 |
109 |
0.001734 |
0.006974 |
1164 |
NON CANONICAL WNT SIGNALING PATHWAY |
8 |
140 |
0.001751 |
0.007001 |
1165 |
REGULATION OF FIBROBLAST PROLIFERATION |
6 |
81 |
0.001783 |
0.007116 |
1166 |
REGULATION OF JUN KINASE ACTIVITY |
6 |
81 |
0.001783 |
0.007116 |
1167 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
7 |
110 |
0.001827 |
0.007284 |
1168 |
ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY |
3 |
16 |
0.001878 |
0.007375 |
1169 |
REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
3 |
16 |
0.001878 |
0.007375 |
1170 |
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
3 |
16 |
0.001878 |
0.007375 |
1171 |
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION |
3 |
16 |
0.001878 |
0.007375 |
1172 |
CARDIAC MYOFIBRIL ASSEMBLY |
3 |
16 |
0.001878 |
0.007375 |
1173 |
REGULATION OF MONONUCLEAR CELL MIGRATION |
3 |
16 |
0.001878 |
0.007375 |
1174 |
REGULATION OF MACROPHAGE CHEMOTAXIS |
3 |
16 |
0.001878 |
0.007375 |
1175 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
3 |
16 |
0.001878 |
0.007375 |
1176 |
POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY |
3 |
16 |
0.001878 |
0.007375 |
1177 |
REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT |
3 |
16 |
0.001878 |
0.007375 |
1178 |
CARDIAC RIGHT VENTRICLE MORPHOGENESIS |
3 |
16 |
0.001878 |
0.007375 |
1179 |
MEGAKARYOCYTE DEVELOPMENT |
3 |
16 |
0.001878 |
0.007375 |
1180 |
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
3 |
16 |
0.001878 |
0.007375 |
1181 |
PARAXIAL MESODERM DEVELOPMENT |
3 |
16 |
0.001878 |
0.007375 |
1182 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
3 |
16 |
0.001878 |
0.007375 |
1183 |
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE |
3 |
16 |
0.001878 |
0.007375 |
1184 |
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS |
3 |
16 |
0.001878 |
0.007375 |
1185 |
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS |
3 |
16 |
0.001878 |
0.007375 |
1186 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
5 |
56 |
0.001885 |
0.007389 |
1187 |
PEPTIDE CROSS LINKING |
5 |
56 |
0.001885 |
0.007389 |
1188 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
34 |
0.001951 |
0.007604 |
1189 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
34 |
0.001951 |
0.007604 |
1190 |
REGULATION OF PROTEIN DEACETYLATION |
4 |
34 |
0.001951 |
0.007604 |
1191 |
PROTEIN DESTABILIZATION |
4 |
34 |
0.001951 |
0.007604 |
1192 |
OLIGODENDROCYTE DEVELOPMENT |
4 |
34 |
0.001951 |
0.007604 |
1193 |
NEURAL TUBE PATTERNING |
4 |
34 |
0.001951 |
0.007604 |
1194 |
BRAIN MORPHOGENESIS |
4 |
34 |
0.001951 |
0.007604 |
1195 |
POSITIVE REGULATION OF PROTEIN SECRETION |
10 |
211 |
0.002004 |
0.007798 |
1196 |
SKIN DEVELOPMENT |
10 |
211 |
0.002004 |
0.007798 |
1197 |
ORGAN REGENERATION |
6 |
83 |
0.00202 |
0.007846 |
1198 |
REGULATION OF POTASSIUM ION TRANSPORT |
6 |
83 |
0.00202 |
0.007846 |
1199 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
12 |
285 |
0.002023 |
0.007849 |
1200 |
ZYMOGEN ACTIVATION |
7 |
112 |
0.002025 |
0.007852 |
1201 |
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
5 |
57 |
0.00204 |
0.007897 |
1202 |
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
5 |
57 |
0.00204 |
0.007897 |
1203 |
REGULATION OF AUTOPHAGY |
11 |
249 |
0.00212 |
0.008198 |
1204 |
NEGATIVE REGULATION OF WOUND HEALING |
5 |
58 |
0.002204 |
0.008518 |
1205 |
REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION |
3 |
17 |
0.002254 |
0.008639 |
1206 |
EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS |
3 |
17 |
0.002254 |
0.008639 |
1207 |
NEGATIVE REGULATION OF STEM CELL PROLIFERATION |
3 |
17 |
0.002254 |
0.008639 |
1208 |
POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
3 |
17 |
0.002254 |
0.008639 |
1209 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
7 |
114 |
0.00224 |
0.008639 |
1210 |
DORSAL VENTRAL NEURAL TUBE PATTERNING |
3 |
17 |
0.002254 |
0.008639 |
1211 |
MAMMARY GLAND ALVEOLUS DEVELOPMENT |
3 |
17 |
0.002254 |
0.008639 |
1212 |
MAMMARY GLAND LOBULE DEVELOPMENT |
3 |
17 |
0.002254 |
0.008639 |
1213 |
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
3 |
17 |
0.002254 |
0.008639 |
1214 |
DEFINITIVE HEMOPOIESIS |
3 |
17 |
0.002254 |
0.008639 |
1215 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
26 |
898 |
0.002264 |
0.008669 |
1216 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
85 |
0.00228 |
0.008704 |
1217 |
PALATE DEVELOPMENT |
6 |
85 |
0.00228 |
0.008704 |
1218 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
6 |
85 |
0.00228 |
0.008704 |
1219 |
POSITIVE REGULATION OF CHROMATIN MODIFICATION |
6 |
85 |
0.00228 |
0.008704 |
1220 |
RESPONSE TO CALCIUM ION |
7 |
115 |
0.002353 |
0.008975 |
1221 |
REGULATION OF T CELL PROLIFERATION |
8 |
147 |
0.002378 |
0.009054 |
1222 |
REGULATION OF GLIAL CELL DIFFERENTIATION |
5 |
59 |
0.002378 |
0.009054 |
1223 |
REGULATION OF CELL CYCLE |
27 |
949 |
0.00239 |
0.009094 |
1224 |
POSITIVE REGULATION OF SECRETION |
14 |
370 |
0.002397 |
0.009113 |
1225 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
4 |
36 |
0.002418 |
0.00916 |
1226 |
T CELL PROLIFERATION |
4 |
36 |
0.002418 |
0.00916 |
1227 |
NEGATIVE REGULATION OF HISTONE MODIFICATION |
4 |
36 |
0.002418 |
0.00916 |
1228 |
POSITIVE REGULATION OF PROTEIN ACETYLATION |
4 |
36 |
0.002418 |
0.00916 |
1229 |
POSITIVE REGULATION OF B CELL ACTIVATION |
6 |
86 |
0.002419 |
0.00916 |
1230 |
RESPONSE TO TEMPERATURE STIMULUS |
8 |
148 |
0.00248 |
0.009382 |
1231 |
RESPONSE TO RADIATION |
15 |
413 |
0.002516 |
0.009511 |
1232 |
REGULATION OF GLUCOSE IMPORT |
5 |
60 |
0.002561 |
0.009663 |
1233 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
5 |
60 |
0.002561 |
0.009663 |
1234 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
6 |
87 |
0.002565 |
0.009671 |
1235 |
REGULATION OF CYTOKINE SECRETION |
8 |
149 |
0.002586 |
0.009742 |
1236 |
REGULATION OF RECEPTOR ACTIVITY |
7 |
117 |
0.002594 |
0.009756 |
1237 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
7 |
117 |
0.002594 |
0.009756 |
1238 |
REGULATION OF MITOCHONDRIAL DEPOLARIZATION |
3 |
18 |
0.002673 |
0.009935 |
1239 |
POSITIVE REGULATION OF B CELL PROLIFERATION |
4 |
37 |
0.002678 |
0.009935 |
1240 |
LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT |
3 |
18 |
0.002673 |
0.009935 |
1241 |
CATECHOLAMINE BIOSYNTHETIC PROCESS |
3 |
18 |
0.002673 |
0.009935 |
1242 |
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS |
3 |
18 |
0.002673 |
0.009935 |
1243 |
RESPONSE TO CAFFEINE |
3 |
18 |
0.002673 |
0.009935 |
1244 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
4 |
37 |
0.002678 |
0.009935 |
1245 |
KIDNEY MESENCHYME DEVELOPMENT |
3 |
18 |
0.002673 |
0.009935 |
1246 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
4 |
37 |
0.002678 |
0.009935 |
1247 |
POSITIVE REGULATION OF PROTEIN DEACETYLATION |
3 |
18 |
0.002673 |
0.009935 |
1248 |
ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY |
4 |
37 |
0.002678 |
0.009935 |
1249 |
OSTEOBLAST DEVELOPMENT |
3 |
18 |
0.002673 |
0.009935 |
1250 |
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY |
4 |
37 |
0.002678 |
0.009935 |
1251 |
NEPHRON TUBULE FORMATION |
3 |
18 |
0.002673 |
0.009935 |
1252 |
MUSCLE CELL MIGRATION |
3 |
18 |
0.002673 |
0.009935 |
1253 |
UTERUS DEVELOPMENT |
3 |
18 |
0.002673 |
0.009935 |
1254 |
CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS |
3 |
18 |
0.002673 |
0.009935 |